GO Terms |
Score |
Description |
GO:0008150 |
83.12% |
biological_process |
GO:0050896 |
65.63% |
response to stimulus |
GO:0065007 |
58.53% |
biological regulation |
GO:0050789 |
57.57% |
regulation of biological process |
GO:0050794 |
56.91% |
regulation of cellular process |
GO:0031323 |
56.27% |
regulation of cellular metabolic process |
GO:0019222 |
55.72% |
regulation of metabolic process |
GO:0060255 |
53.12% |
regulation of macromolecule metabolic process |
GO:0080090 |
47.70% |
regulation of primary metabolic process |
GO:0051171 |
46.25% |
regulation of nitrogen compound metabolic process |
GO:0048519 |
45.80% |
negative regulation of biological process |
GO:0048523 |
45.17% |
negative regulation of cellular process |
GO:0006950 |
42.58% |
response to stress |
GO:0032268 |
42.27% |
regulation of cellular protein metabolic process |
GO:0051246 |
42.15% |
regulation of protein metabolic process |
GO:0009987 |
39.13% |
cellular process |
GO:0048518 |
37.49% |
positive regulation of biological process |
GO:0048522 |
37.48% |
positive regulation of cellular process |
GO:0030162 |
37.32% |
regulation of proteolysis |
GO:0009892 |
37.13% |
negative regulation of metabolic process |
GO:0031324 |
36.41% |
negative regulation of cellular metabolic process |
GO:0045861 |
35.87% |
negative regulation of proteolysis |
GO:0051172 |
35.39% |
negative regulation of nitrogen compound metabolic process |
GO:0010605 |
34.81% |
negative regulation of macromolecule metabolic process |
GO:0051239 |
34.36% |
regulation of multicellular organismal process |
GO:0031325 |
34.18% |
positive regulation of cellular metabolic process |
GO:0009893 |
34.07% |
positive regulation of metabolic process |
GO:0032269 |
33.88% |
negative regulation of cellular protein metabolic process |
GO:0010604 |
33.87% |
positive regulation of macromolecule metabolic process |
GO:0051248 |
33.39% |
negative regulation of protein metabolic process |
GO:0065009 |
31.58% |
regulation of molecular function |
GO:0050793 |
31.11% |
regulation of developmental process |
GO:0006952 |
30.90% |
defense response |
GO:0031329 |
30.44% |
regulation of cellular catabolic process |
GO:0032502 |
30.16% |
developmental process |
GO:0050790 |
30.01% |
regulation of catalytic activity |
GO:0052547 |
29.77% |
regulation of peptidase activity |
GO:0051346 |
29.75% |
negative regulation of hydrolase activity |
GO:0009894 |
29.05% |
regulation of catabolic process |
GO:0048856 |
28.60% |
anatomical structure development |
GO:0008284 |
28.58% |
positive regulation of cell population proliferation |
GO:0051336 |
28.49% |
regulation of hydrolase activity |
GO:0010466 |
28.29% |
negative regulation of peptidase activity |
GO:0043086 |
28.09% |
negative regulation of catalytic activity |
GO:0051128 |
27.96% |
regulation of cellular component organization |
GO:0044092 |
27.44% |
negative regulation of molecular function |
GO:0042127 |
27.03% |
regulation of cell population proliferation |
GO:0031330 |
26.94% |
negative regulation of cellular catabolic process |
GO:0009895 |
26.12% |
negative regulation of catabolic process |
GO:0009889 |
26.11% |
regulation of biosynthetic process |
GO:0045740 |
25.75% |
positive regulation of DNA replication |
GO:0010712 |
25.62% |
regulation of collagen metabolic process |
GO:0022603 |
25.54% |
regulation of anatomical structure morphogenesis |
GO:0006275 |
25.42% |
regulation of DNA replication |
GO:0071840 |
25.39% |
cellular component organization or biogenesis |
GO:0016043 |
25.29% |
cellular component organization |
GO:0010941 |
25.27% |
regulation of cell death |
GO:0031326 |
24.88% |
regulation of cellular biosynthetic process |
GO:0043067 |
24.87% |
regulation of programmed cell death |
GO:0048869 |
24.81% |
cellular developmental process |
GO:0051241 |
24.70% |
negative regulation of multicellular organismal process |
GO:0051093 |
24.69% |
negative regulation of developmental process |
GO:0042176 |
23.95% |
regulation of protein catabolic process |
GO:0009891 |
23.85% |
positive regulation of biosynthetic process |
GO:0009605 |
23.73% |
response to external stimulus |
GO:0010556 |
23.30% |
regulation of macromolecule biosynthetic process |
GO:2000112 |
23.22% |
regulation of cellular macromolecule biosynthetic process |
GO:0051129 |
23.00% |
negative regulation of cellular component organization |
GO:0042221 |
22.85% |
response to chemical |
GO:0060548 |
22.78% |
negative regulation of cell death |
GO:0042177 |
22.70% |
negative regulation of protein catabolic process |
GO:0010033 |
22.40% |
response to organic substance |
GO:0031328 |
22.37% |
positive regulation of cellular biosynthetic process |
GO:0010557 |
21.99% |
positive regulation of macromolecule biosynthetic process |
GO:0097435 |
21.59% |
supramolecular fiber organization |
GO:0006979 |
21.53% |
response to oxidative stress |
GO:1903053 |
21.37% |
regulation of extracellular matrix organization |
GO:0034104 |
20.92% |
negative regulation of tissue remodeling |
GO:0034103 |
20.77% |
regulation of tissue remodeling |
GO:0051716 |
20.67% |
cellular response to stimulus |
GO:1903018 |
19.66% |
regulation of glycoprotein metabolic process |
GO:0009628 |
18.83% |
response to abiotic stimulus |
GO:1901700 |
18.77% |
response to oxygen-containing compound |
GO:0009725 |
18.52% |
response to hormone |
GO:0009719 |
18.44% |
response to endogenous stimulus |
GO:0048513 |
18.43% |
animal organ development |
GO:0022414 |
18.25% |
reproductive process |
GO:0009991 |
18.09% |
response to extracellular stimulus |
GO:0051173 |
18.08% |
positive regulation of nitrogen compound metabolic process |
GO:0009593 |
17.87% |
detection of chemical stimulus |
GO:0033993 |
17.78% |
response to lipid |
GO:0051606 |
17.76% |
detection of stimulus |
GO:0031667 |
17.60% |
response to nutrient levels |
GO:0014070 |
17.59% |
response to organic cyclic compound |
GO:0070887 |
17.58% |
cellular response to chemical stimulus |
GO:0050906 |
17.36% |
detection of stimulus involved in sensory perception |
GO:0001580 |
17.31% |
detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0070482 |
17.28% |
response to oxygen levels |
GO:0050912 |
17.26% |
detection of chemical stimulus involved in sensory perception of taste |
GO:0050907 |
17.17% |
detection of chemical stimulus involved in sensory perception |
GO:0006955 |
17.10% |
immune response |
GO:0033554 |
17.09% |
cellular response to stress |
GO:0003006 |
17.08% |
developmental process involved in reproduction |
GO:0008219 |
16.66% |
cell death |
GO:0002376 |
16.25% |
immune system process |
GO:0065008 |
16.18% |
regulation of biological quality |
GO:0006915 |
16.02% |
apoptotic process |
GO:0012501 |
15.80% |
programmed cell death |
GO:0036293 |
15.68% |
response to decreased oxygen levels |
GO:0008406 |
15.57% |
gonad development |
GO:0048468 |
15.56% |
cell development |
GO:0001666 |
15.50% |
response to hypoxia |
GO:0032355 |
15.48% |
response to estradiol |
GO:0009636 |
15.44% |
response to toxic substance |
GO:0009611 |
15.36% |
response to wounding |
GO:0007610 |
15.30% |
behavior |
GO:0051240 |
15.28% |
positive regulation of multicellular organismal process |
GO:0042493 |
15.21% |
response to drug |
GO:0010035 |
15.13% |
response to inorganic substance |
GO:0046677 |
14.88% |
response to antibiotic |
GO:0009607 |
14.84% |
response to biotic stimulus |
GO:1901701 |
14.74% |
cellular response to oxygen-containing compound |
GO:0043207 |
14.74% |
response to external biotic stimulus |
GO:0030154 |
14.74% |
cell differentiation |
GO:0008584 |
14.60% |
male gonad development |
GO:0048511 |
14.24% |
rhythmic process |
GO:0009410 |
14.22% |
response to xenobiotic stimulus |
GO:0048732 |
14.15% |
gland development |
GO:0051704 |
14.13% |
multi-organism process |
GO:0001775 |
14.02% |
cell activation |
GO:0000302 |
13.67% |
response to reactive oxygen species |
GO:0048608 |
13.60% |
reproductive structure development |
GO:0007623 |
13.52% |
circadian rhythm |
GO:0042542 |
13.43% |
response to hydrogen peroxide |
GO:0042592 |
13.40% |
homeostatic process |
GO:0034614 |
13.25% |
cellular response to reactive oxygen species |
GO:0051707 |
13.19% |
response to other organism |
GO:0097237 |
12.92% |
cellular response to toxic substance |
GO:0048583 |
12.89% |
regulation of response to stimulus |
GO:0051094 |
12.70% |
positive regulation of developmental process |
GO:0071236 |
12.59% |
cellular response to antibiotic |
GO:0032501 |
12.49% |
multicellular organismal process |
GO:0009743 |
12.46% |
response to carbohydrate |
GO:0035690 |
12.37% |
cellular response to drug |
GO:2000026 |
12.31% |
regulation of multicellular organismal development |
GO:0010468 |
12.19% |
regulation of gene expression |
GO:0070301 |
12.05% |
cellular response to hydrogen peroxide |
GO:0001934 |
12.05% |
positive regulation of protein phosphorylation |
GO:0042325 |
11.98% |
regulation of phosphorylation |
GO:0098542 |
11.96% |
defense response to other organism |
GO:0034599 |
11.92% |
cellular response to oxidative stress |
GO:0007622 |
11.79% |
rhythmic behavior |
GO:0051247 |
11.76% |
positive regulation of protein metabolic process |
GO:0032270 |
11.73% |
positive regulation of cellular protein metabolic process |
GO:0042327 |
11.73% |
positive regulation of phosphorylation |
GO:0009653 |
11.64% |
anatomical structure morphogenesis |
GO:0048512 |
11.62% |
circadian behavior |
GO:0048678 |
11.56% |
response to axon injury |
GO:0001932 |
11.48% |
regulation of protein phosphorylation |
GO:0019220 |
11.40% |
regulation of phosphate metabolic process |
GO:0051174 |
11.40% |
regulation of phosphorus metabolic process |
GO:0009617 |
11.23% |
response to bacterium |
GO:0009888 |
11.17% |
tissue development |
GO:0001894 |
11.11% |
tissue homeostasis |
GO:0007566 |
10.95% |
embryo implantation |
GO:0007423 |
10.82% |
sensory organ development |
GO:0060249 |
10.74% |
anatomical structure homeostasis |
GO:0007165 |
10.64% |
signal transduction |
GO:0045937 |
10.60% |
positive regulation of phosphate metabolic process |
GO:0006959 |
10.59% |
humoral immune response |
GO:0080134 |
10.46% |
regulation of response to stress |
GO:0042742 |
10.40% |
defense response to bacterium |
GO:0010562 |
10.30% |
positive regulation of phosphorus metabolic process |
GO:0048584 |
10.16% |
positive regulation of response to stimulus |
GO:0051962 |
10.15% |
positive regulation of nervous system development |
GO:0002064 |
10.13% |
epithelial cell development |
GO:0050679 |
9.89% |
positive regulation of epithelial cell proliferation |
GO:0019730 |
9.85% |
antimicrobial humoral response |
GO:0001654 |
9.83% |
eye development |
GO:0031401 |
9.83% |
positive regulation of protein modification process |
GO:0007420 |
9.82% |
brain development |
GO:0007154 |
9.80% |
cell communication |
GO:0010628 |
9.53% |
positive regulation of gene expression |
GO:0052548 |
9.49% |
regulation of endopeptidase activity |
GO:0050678 |
9.49% |
regulation of epithelial cell proliferation |
GO:0003008 |
9.44% |
system process |
GO:0050727 |
9.25% |
regulation of inflammatory response |
GO:0061844 |
9.23% |
antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0006954 |
9.18% |
inflammatory response |
GO:0042981 |
9.13% |
regulation of apoptotic process |
GO:0048585 |
9.09% |
negative regulation of response to stimulus |
GO:0031644 |
9.03% |
regulation of nervous system process |
GO:0007281 |
8.99% |
germ cell development |
GO:0007166 |
8.99% |
cell surface receptor signaling pathway |
GO:0031347 |
8.95% |
regulation of defense response |
GO:0032101 |
8.92% |
regulation of response to external stimulus |
GO:0021700 |
8.88% |
developmental maturation |
GO:1902531 |
8.85% |
regulation of intracellular signal transduction |
GO:0051960 |
8.82% |
regulation of nervous system development |
GO:1901698 |
8.61% |
response to nitrogen compound |
GO:0019219 |
8.60% |
regulation of nucleobase-containing compound metabolic process |
GO:0045595 |
8.57% |
regulation of cell differentiation |
GO:0007286 |
8.56% |
spermatid development |
GO:0050829 |
8.56% |
defense response to Gram-negative bacterium |
GO:0040008 |
8.55% |
regulation of growth |
GO:0045597 |
8.54% |
positive regulation of cell differentiation |
GO:0044057 |
8.53% |
regulation of system process |
GO:0009967 |
8.43% |
positive regulation of signal transduction |
GO:0031399 |
8.39% |
regulation of protein modification process |
GO:0045087 |
8.33% |
innate immune response |
GO:0010243 |
8.30% |
response to organonitrogen compound |
GO:1902533 |
8.27% |
positive regulation of intracellular signal transduction |
GO:0002237 |
8.26% |
response to molecule of bacterial origin |
GO:0008152 |
8.25% |
metabolic process |
GO:0009966 |
8.22% |
regulation of signal transduction |
GO:0051130 |
8.19% |
positive regulation of cellular component organization |
GO:0032102 |
8.09% |
negative regulation of response to external stimulus |
GO:0008283 |
8.07% |
cell population proliferation |
GO:0023056 |
8.01% |
positive regulation of signaling |
GO:0001895 |
7.98% |
retina homeostasis |
GO:0007267 |
7.97% |
cell-cell signaling |
GO:0023052 |
7.97% |
signaling |
GO:0010951 |
7.95% |
negative regulation of endopeptidase activity |
GO:0048469 |
7.92% |
cell maturation |
GO:2000116 |
7.88% |
regulation of cysteine-type endopeptidase activity |
GO:0010647 |
7.87% |
positive regulation of cell communication |
GO:0045935 |
7.80% |
positive regulation of nucleobase-containing compound metabolic process |
GO:0022412 |
7.79% |
cellular process involved in reproduction in multicellular organism |
GO:0034097 |
7.78% |
response to cytokine |
GO:0010720 |
7.76% |
positive regulation of cell development |
GO:0031960 |
7.75% |
response to corticosteroid |
GO:0010629 |
7.71% |
negative regulation of gene expression |
GO:0071310 |
7.66% |
cellular response to organic substance |
GO:0043069 |
7.65% |
negative regulation of programmed cell death |
GO:0048638 |
7.65% |
regulation of developmental growth |
GO:0060284 |
7.58% |
regulation of cell development |
GO:0044093 |
7.55% |
positive regulation of molecular function |
GO:0043066 |
7.48% |
negative regulation of apoptotic process |
GO:0023051 |
7.43% |
regulation of signaling |
GO:0071496 |
7.42% |
cellular response to external stimulus |
GO:0009314 |
7.36% |
response to radiation |
GO:0010646 |
7.36% |
regulation of cell communication |
GO:0010976 |
7.34% |
positive regulation of neuron projection development |
GO:0007218 |
7.33% |
neuropeptide signaling pathway |
GO:0043408 |
7.32% |
regulation of MAPK cascade |
GO:0048232 |
7.32% |
male gamete generation |
GO:0031346 |
7.30% |
positive regulation of cell projection organization |
GO:0070613 |
7.29% |
regulation of protein processing |
GO:0031348 |
7.28% |
negative regulation of defense response |
GO:0007568 |
7.28% |
aging |
GO:0051384 |
7.28% |
response to glucocorticoid |
GO:0002682 |
7.23% |
regulation of immune system process |
GO:0080135 |
7.23% |
regulation of cellular response to stress |
GO:0007283 |
7.13% |
spermatogenesis |
GO:0032496 |
7.11% |
response to lipopolysaccharide |
GO:0050769 |
7.05% |
positive regulation of neurogenesis |
GO:0035821 |
7.04% |
modification of morphology or physiology of other organism |
GO:0022607 |
7.00% |
cellular component assembly |
GO:0001817 |
7.00% |
regulation of cytokine production |
GO:1901360 |
6.96% |
organic cyclic compound metabolic process |
GO:0048609 |
6.96% |
multicellular organismal reproductive process |
GO:0050728 |
6.95% |
negative regulation of inflammatory response |
GO:0044419 |
6.92% |
interspecies interaction between organisms |
GO:0007167 |
6.90% |
enzyme linked receptor protein signaling pathway |
GO:0007276 |
6.88% |
gamete generation |
GO:0044237 |
6.85% |
cellular metabolic process |
GO:0001819 |
6.84% |
positive regulation of cytokine production |
GO:0006928 |
6.76% |
movement of cell or subcellular component |
GO:0002062 |
6.76% |
chondrocyte differentiation |
GO:0009887 |
6.75% |
animal organ morphogenesis |
GO:0043410 |
6.69% |
positive regulation of MAPK cascade |
GO:0043434 |
6.68% |
response to peptide hormone |
GO:1903317 |
6.67% |
regulation of protein maturation |
GO:0002526 |
6.64% |
acute inflammatory response |
GO:1901215 |
6.63% |
negative regulation of neuron death |
GO:0008285 |
6.62% |
negative regulation of cell population proliferation |
GO:0001101 |
6.60% |
response to acid chemical |
GO:1901652 |
6.59% |
response to peptide |
GO:0045786 |
6.58% |
negative regulation of cell cycle |
GO:0048646 |
6.58% |
anatomical structure formation involved in morphogenesis |
GO:0051252 |
6.56% |
regulation of RNA metabolic process |
GO:0009890 |
6.54% |
negative regulation of biosynthetic process |
GO:0006725 |
6.54% |
cellular aromatic compound metabolic process |
GO:0010942 |
6.51% |
positive regulation of cell death |
GO:0062012 |
6.47% |
regulation of small molecule metabolic process |
GO:0050830 |
6.46% |
defense response to Gram-positive bacterium |
GO:0032677 |
6.44% |
regulation of interleukin-8 production |
GO:0007569 |
6.41% |
cell aging |
GO:0043170 |
6.40% |
macromolecule metabolic process |
GO:0045666 |
6.39% |
positive regulation of neuron differentiation |
GO:0048545 |
6.36% |
response to steroid hormone |
GO:0050795 |
6.36% |
regulation of behavior |
GO:0043068 |
6.33% |
positive regulation of programmed cell death |
GO:0031668 |
6.32% |
cellular response to extracellular stimulus |
GO:0002443 |
6.29% |
leukocyte mediated immunity |
GO:0006953 |
6.28% |
acute-phase response |
GO:0051052 |
6.28% |
regulation of DNA metabolic process |
GO:0045930 |
6.25% |
negative regulation of mitotic cell cycle |
GO:0002683 |
6.22% |
negative regulation of immune system process |
GO:0043065 |
6.22% |
positive regulation of apoptotic process |
GO:0009416 |
6.21% |
response to light stimulus |
GO:0006355 |
6.20% |
regulation of transcription, DNA-templated |
GO:0097305 |
6.20% |
response to alcohol |
GO:0002252 |
6.19% |
immune effector process |
GO:2001141 |
6.19% |
regulation of RNA biosynthetic process |
GO:0071704 |
6.19% |
organic substance metabolic process |
GO:0040011 |
6.18% |
locomotion |
GO:0031646 |
6.17% |
positive regulation of nervous system process |
GO:0001906 |
6.16% |
cell killing |
GO:0048146 |
6.16% |
positive regulation of fibroblast proliferation |
GO:0031214 |
6.15% |
biomineral tissue development |
GO:0110148 |
6.11% |
biomineralization |
GO:1903506 |
6.08% |
regulation of nucleic acid-templated transcription |
GO:0010467 |
6.07% |
gene expression |
GO:0045862 |
6.05% |
positive regulation of proteolysis |
GO:0070372 |
6.05% |
regulation of ERK1 and ERK2 cascade |
GO:0070997 |
6.05% |
neuron death |
GO:0050767 |
6.04% |
regulation of neurogenesis |
GO:0070374 |
6.00% |
positive regulation of ERK1 and ERK2 cascade |
GO:0010506 |
5.98% |
regulation of autophagy |
GO:0009266 |
5.95% |
response to temperature stimulus |
GO:0071495 |
5.94% |
cellular response to endogenous stimulus |
GO:0050877 |
5.91% |
nervous system process |
GO:0031327 |
5.90% |
negative regulation of cellular biosynthetic process |
GO:0071453 |
5.87% |
cellular response to oxygen levels |
GO:0006810 |
5.84% |
transport |
GO:0051254 |
5.84% |
positive regulation of RNA metabolic process |
GO:1901214 |
5.84% |
regulation of neuron death |
GO:0019221 |
5.83% |
cytokine-mediated signaling pathway |
GO:0031669 |
5.78% |
cellular response to nutrient levels |
GO:0001909 |
5.78% |
leukocyte mediated cytotoxicity |
GO:2000117 |
5.78% |
negative regulation of cysteine-type endopeptidase activity |
GO:0043085 |
5.77% |
positive regulation of catalytic activity |
GO:0071216 |
5.76% |
cellular response to biotic stimulus |
GO:0104004 |
5.76% |
cellular response to environmental stimulus |
GO:0051234 |
5.74% |
establishment of localization |
GO:0071214 |
5.69% |
cellular response to abiotic stimulus |
GO:0010608 |
5.68% |
posttranscriptional regulation of gene expression |
GO:0042594 |
5.68% |
response to starvation |
GO:0002694 |
5.67% |
regulation of leukocyte activation |
GO:0150077 |
5.67% |
regulation of neuroinflammatory response |
GO:0051179 |
5.60% |
localization |
GO:0071345 |
5.59% |
cellular response to cytokine stimulus |
GO:0031641 |
5.56% |
regulation of myelination |
GO:0007169 |
5.55% |
transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0001558 |
5.54% |
regulation of cell growth |
GO:2000241 |
5.52% |
regulation of reproductive process |
GO:0046427 |
5.52% |
positive regulation of receptor signaling pathway via JAK-STAT |
GO:0048870 |
5.50% |
cell motility |
GO:0032757 |
5.49% |
positive regulation of interleukin-8 production |
GO:0043030 |
5.49% |
regulation of macrophage activation |
GO:0050673 |
5.45% |
epithelial cell proliferation |
GO:0008544 |
5.44% |
epidermis development |
GO:0006919 |
5.44% |
activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0046483 |
5.42% |
heterocycle metabolic process |
GO:0006807 |
5.41% |
nitrogen compound metabolic process |
GO:0048534 |
5.41% |
hematopoietic or lymphoid organ development |
GO:0050865 |
5.40% |
regulation of cell activation |
GO:0044238 |
5.40% |
primary metabolic process |
GO:0051881 |
5.39% |
regulation of mitochondrial membrane potential |
GO:0045927 |
5.39% |
positive regulation of growth |
GO:2000242 |
5.39% |
negative regulation of reproductive process |
GO:0048731 |
5.36% |
system development |
GO:1903706 |
5.35% |
regulation of hemopoiesis |
GO:0034644 |
5.35% |
cellular response to UV |
GO:1903508 |
5.30% |
positive regulation of nucleic acid-templated transcription |
GO:0031331 |
5.29% |
positive regulation of cellular catabolic process |
GO:0010955 |
5.28% |
negative regulation of protein processing |
GO:0034612 |
5.28% |
response to tumor necrosis factor |
GO:1902680 |
5.27% |
positive regulation of RNA biosynthetic process |
GO:0045321 |
5.26% |
leukocyte activation |
GO:0071542 |
5.26% |
dopaminergic neuron differentiation |
GO:0030099 |
5.25% |
myeloid cell differentiation |
GO:0045893 |
5.24% |
positive regulation of transcription, DNA-templated |
GO:0090304 |
5.23% |
nucleic acid metabolic process |
GO:0010927 |
5.22% |
cellular component assembly involved in morphogenesis |
GO:1904894 |
5.21% |
positive regulation of receptor signaling pathway via STAT |
GO:1903318 |
5.21% |
negative regulation of protein maturation |
GO:0010948 |
5.20% |
negative regulation of cell cycle process |
GO:0043933 |
5.20% |
protein-containing complex subunit organization |
GO:0019216 |
5.20% |
regulation of lipid metabolic process |
GO:1901654 |
5.18% |
response to ketone |
GO:0071396 |
5.17% |
cellular response to lipid |
GO:0048145 |
5.17% |
regulation of fibroblast proliferation |
GO:0043524 |
5.16% |
negative regulation of neuron apoptotic process |
GO:0001938 |
5.14% |
positive regulation of endothelial cell proliferation |
GO:0070555 |
5.12% |
response to interleukin-1 |
GO:2001233 |
5.12% |
regulation of apoptotic signaling pathway |
GO:0072593 |
5.10% |
reactive oxygen species metabolic process |
GO:0048565 |
5.10% |
digestive tract development |
GO:0002702 |
5.07% |
positive regulation of production of molecular mediator of immune response |
GO:0006986 |
5.04% |
response to unfolded protein |
GO:0048872 |
5.03% |
homeostasis of number of cells |
GO:0051726 |
5.03% |
regulation of cell cycle |
GO:0007275 |
5.02% |
multicellular organism development |
GO:0043523 |
5.02% |
regulation of neuron apoptotic process |
GO:0009896 |
5.02% |
positive regulation of catabolic process |
GO:0032098 |
5.01% |
regulation of appetite |
GO:1903205 |
5.01% |
regulation of hydrogen peroxide-induced cell death |
GO:0071456 |
4.98% |
cellular response to hypoxia |
GO:0006629 |
4.97% |
lipid metabolic process |
GO:0065003 |
4.97% |
protein-containing complex assembly |
GO:0007600 |
4.95% |
sensory perception |
GO:0051930 |
4.94% |
regulation of sensory perception of pain |
GO:0071356 |
4.93% |
cellular response to tumor necrosis factor |
GO:0051385 |
4.93% |
response to mineralocorticoid |
GO:0018958 |
4.93% |
phenol-containing compound metabolic process |
GO:0016070 |
4.93% |
RNA metabolic process |
GO:0010975 |
4.92% |
regulation of neuron projection development |
GO:0071478 |
4.90% |
cellular response to radiation |
GO:0051302 |
4.90% |
regulation of cell division |
GO:0044764 |
4.89% |
multi-organism cellular process |
GO:0051338 |
4.89% |
regulation of transferase activity |
GO:0019835 |
4.87% |
cytolysis |
GO:0045637 |
4.85% |
regulation of myeloid cell differentiation |
GO:0010038 |
4.85% |
response to metal ion |
GO:0035556 |
4.85% |
intracellular signal transduction |
GO:0032879 |
4.81% |
regulation of localization |
GO:0045187 |
4.81% |
regulation of circadian sleep/wake cycle, sleep |
GO:2000278 |
4.80% |
regulation of DNA biosynthetic process |
GO:0007186 |
4.80% |
G protein-coupled receptor signaling pathway |
GO:0045333 |
4.79% |
cellular respiration |
GO:0002449 |
4.78% |
lymphocyte mediated immunity |
GO:0090329 |
4.77% |
regulation of DNA-dependent DNA replication |
GO:0022600 |
4.76% |
digestive system process |
GO:0050890 |
4.76% |
cognition |
GO:0050810 |
4.76% |
regulation of steroid biosynthetic process |
GO:0051591 |
4.75% |
response to cAMP |
GO:0030534 |
4.75% |
adult behavior |
GO:0031344 |
4.75% |
regulation of cell projection organization |
GO:0051347 |
4.74% |
positive regulation of transferase activity |
GO:0016525 |
4.73% |
negative regulation of angiogenesis |
GO:0002695 |
4.73% |
negative regulation of leukocyte activation |
GO:0010558 |
4.73% |
negative regulation of macromolecule biosynthetic process |
GO:0001889 |
4.72% |
liver development |
GO:0071229 |
4.72% |
cellular response to acid chemical |
GO:0120035 |
4.72% |
regulation of plasma membrane bounded cell projection organization |
GO:0042698 |
4.72% |
ovulation cycle |
GO:0031334 |
4.71% |
positive regulation of protein complex assembly |
GO:0016477 |
4.70% |
cell migration |
GO:0007631 |
4.70% |
feeding behavior |
GO:0010165 |
4.69% |
response to X-ray |
GO:0040014 |
4.69% |
regulation of multicellular organism growth |
GO:0009612 |
4.68% |
response to mechanical stimulus |
GO:1903555 |
4.68% |
regulation of tumor necrosis factor superfamily cytokine production |
GO:0006139 |
4.68% |
nucleobase-containing compound metabolic process |
GO:0045765 |
4.68% |
regulation of angiogenesis |
GO:0071219 |
4.68% |
cellular response to molecule of bacterial origin |
GO:2001235 |
4.66% |
positive regulation of apoptotic signaling pathway |
GO:0032989 |
4.65% |
cellular component morphogenesis |
GO:0036294 |
4.65% |
cellular response to decreased oxygen levels |
GO:0007160 |
4.64% |
cell-matrix adhesion |
GO:0051931 |
4.63% |
regulation of sensory perception |
GO:0032870 |
4.63% |
cellular response to hormone stimulus |
GO:0030182 |
4.62% |
neuron differentiation |
GO:0034641 |
4.59% |
cellular nitrogen compound metabolic process |
GO:0045664 |
4.59% |
regulation of neuron differentiation |
GO:2001038 |
4.59% |
regulation of cellular response to drug |
GO:0097190 |
4.58% |
apoptotic signaling pathway |
GO:0042749 |
4.58% |
regulation of circadian sleep/wake cycle |
GO:0009566 |
4.57% |
fertilization |
GO:0001936 |
4.55% |
regulation of endothelial cell proliferation |
GO:0009620 |
4.54% |
response to fungus |
GO:0090305 |
4.53% |
nucleic acid phosphodiester bond hydrolysis |
GO:0007605 |
4.52% |
sensory perception of sound |
GO:0006508 |
4.52% |
proteolysis |
GO:0006091 |
4.52% |
generation of precursor metabolites and energy |
GO:1901342 |
4.52% |
regulation of vasculature development |
GO:0072089 |
4.49% |
stem cell proliferation |
GO:0019098 |
4.49% |
reproductive behavior |
GO:1903859 |
4.47% |
regulation of dendrite extension |
GO:0002521 |
4.47% |
leukocyte differentiation |
GO:0007626 |
4.47% |
locomotory behavior |
GO:0046425 |
4.47% |
regulation of receptor signaling pathway via JAK-STAT |
GO:0051852 |
4.47% |
disruption by host of symbiont cells |
GO:0008344 |
4.46% |
adult locomotory behavior |
GO:0006996 |
4.46% |
organelle organization |
GO:2000181 |
4.44% |
negative regulation of blood vessel morphogenesis |
GO:0031640 |
4.44% |
killing of cells of other organism |
GO:0042752 |
4.44% |
regulation of circadian rhythm |
GO:1904892 |
4.43% |
regulation of receptor signaling pathway via STAT |
GO:0032722 |
4.43% |
positive regulation of chemokine production |
GO:0035295 |
4.42% |
tube development |
GO:0046890 |
4.42% |
regulation of lipid biosynthetic process |
GO:1901343 |
4.41% |
negative regulation of vasculature development |
GO:0006457 |
4.39% |
protein folding |
GO:0023057 |
4.39% |
negative regulation of signaling |
GO:0010212 |
4.39% |
response to ionizing radiation |
GO:0050866 |
4.39% |
negative regulation of cell activation |
GO:0031099 |
4.39% |
regeneration |
GO:0002274 |
4.38% |
myeloid leukocyte activation |
GO:0032103 |
4.37% |
positive regulation of response to external stimulus |
GO:0035966 |
4.36% |
response to topologically incorrect protein |
GO:0030878 |
4.36% |
thyroid gland development |
GO:0051784 |
4.35% |
negative regulation of nuclear division |
GO:1901564 |
4.35% |
organonitrogen compound metabolic process |
GO:0045944 |
4.35% |
positive regulation of transcription by RNA polymerase II |
GO:0048589 |
4.35% |
developmental growth |
GO:0045934 |
4.34% |
negative regulation of nucleobase-containing compound metabolic process |
GO:0048878 |
4.33% |
chemical homeostasis |
GO:2000377 |
4.33% |
regulation of reactive oxygen species metabolic process |
GO:0033363 |
4.32% |
secretory granule organization |
GO:0044706 |
4.32% |
multi-multicellular organism process |
GO:0051873 |
4.32% |
killing by host of symbiont cells |
GO:0010648 |
4.32% |
negative regulation of cell communication |
GO:0043281 |
4.31% |
regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0043254 |
4.30% |
regulation of protein complex assembly |
GO:2000113 |
4.30% |
negative regulation of cellular macromolecule biosynthetic process |
GO:0015980 |
4.30% |
energy derivation by oxidation of organic compounds |
GO:1901031 |
4.30% |
regulation of response to reactive oxygen species |
GO:0006974 |
4.29% |
cellular response to DNA damage stimulus |
GO:1903201 |
4.28% |
regulation of oxidative stress-induced cell death |
GO:0060259 |
4.28% |
regulation of feeding behavior |
GO:0031349 |
4.27% |
positive regulation of defense response |
GO:0071347 |
4.26% |
cellular response to interleukin-1 |
GO:0006357 |
4.26% |
regulation of transcription by RNA polymerase II |
GO:0002067 |
4.26% |
glandular epithelial cell differentiation |
GO:0009267 |
4.25% |
cellular response to starvation |
GO:0043549 |
4.24% |
regulation of kinase activity |
GO:1903861 |
4.24% |
positive regulation of dendrite extension |
GO:0045926 |
4.22% |
negative regulation of growth |
GO:0048863 |
4.22% |
stem cell differentiation |
GO:0009056 |
4.21% |
catabolic process |
GO:0044364 |
4.20% |
disruption of cells of other organism |
GO:0051090 |
4.20% |
regulation of DNA-binding transcription factor activity |
GO:0017148 |
4.19% |
negative regulation of translation |
GO:0007584 |
4.19% |
response to nutrient |
GO:0050832 |
4.19% |
defense response to fungus |
GO:0019538 |
4.18% |
protein metabolic process |
GO:0010817 |
4.17% |
regulation of hormone levels |
GO:0002699 |
4.15% |
positive regulation of immune effector process |
GO:0009755 |
4.15% |
hormone-mediated signaling pathway |
GO:0040007 |
4.15% |
growth |
GO:0044703 |
4.15% |
multi-organism reproductive process |
GO:0050729 |
4.14% |
positive regulation of inflammatory response |
GO:0050954 |
4.14% |
sensory perception of mechanical stimulus |
GO:0055114 |
4.14% |
oxidation-reduction process |
GO:1902105 |
4.13% |
regulation of leukocyte differentiation |
GO:0009408 |
4.13% |
response to heat |
GO:1901615 |
4.13% |
organic hydroxy compound metabolic process |
GO:0051091 |
4.13% |
positive regulation of DNA-binding transcription factor activity |
GO:0031100 |
4.11% |
animal organ regeneration |
GO:0006109 |
4.10% |
regulation of carbohydrate metabolic process |
GO:0007049 |
4.09% |
cell cycle |
GO:0051193 |
4.09% |
regulation of cofactor metabolic process |
GO:0030307 |
4.07% |
positive regulation of cell growth |
GO:0007417 |
4.07% |
central nervous system development |
GO:0009790 |
4.06% |
embryo development |
GO:0051818 |
4.06% |
disruption of cells of other organism involved in symbiotic interaction |
GO:0007005 |
4.06% |
mitochondrion organization |
GO:0042391 |
4.05% |
regulation of membrane potential |
GO:0010669 |
4.05% |
epithelial structure maintenance |
GO:0061351 |
4.05% |
neural precursor cell proliferation |
GO:0006417 |
4.04% |
regulation of translation |
GO:0045859 |
4.03% |
regulation of protein kinase activity |
GO:1903557 |
4.02% |
positive regulation of tumor necrosis factor superfamily cytokine production |
GO:0010564 |
4.02% |
regulation of cell cycle process |
GO:0045471 |
4.02% |
response to ethanol |
GO:0046649 |
4.01% |
lymphocyte activation |
GO:0097421 |
4.01% |
liver regeneration |
GO:0071222 |
4.01% |
cellular response to lipopolysaccharide |
GO:0032680 |
4.00% |
regulation of tumor necrosis factor production |
GO:1903202 |
4.00% |
negative regulation of oxidative stress-induced cell death |
GO:0019731 |
3.99% |
antibacterial humoral response |
GO:0006468 |
3.98% |
protein phosphorylation |
GO:0022904 |
3.98% |
respiratory electron transport chain |
GO:2000177 |
3.98% |
regulation of neural precursor cell proliferation |
GO:0048017 |
3.98% |
inositol lipid-mediated signaling |
GO:0033574 |
3.97% |
response to testosterone |
GO:0045639 |
3.96% |
positive regulation of myeloid cell differentiation |
GO:0048639 |
3.96% |
positive regulation of developmental growth |
GO:0009411 |
3.96% |
response to UV |
GO:1900407 |
3.95% |
regulation of cellular response to oxidative stress |
GO:0051883 |
3.94% |
killing of cells in other organism involved in symbiotic interaction |
GO:0051054 |
3.94% |
positive regulation of DNA metabolic process |
GO:0044248 |
3.93% |
cellular catabolic process |
GO:0071900 |
3.92% |
regulation of protein serine/threonine kinase activity |
GO:1903203 |
3.92% |
regulation of oxidative stress-induced neuron death |
GO:0007611 |
3.91% |
learning or memory |
GO:0002684 |
3.91% |
positive regulation of immune system process |
GO:0071417 |
3.90% |
cellular response to organonitrogen compound |
GO:0032094 |
3.90% |
response to food |
GO:0007617 |
3.90% |
mating behavior |
GO:0007219 |
3.90% |
Notch signaling pathway |
GO:0010952 |
3.88% |
positive regulation of peptidase activity |
GO:0045834 |
3.88% |
positive regulation of lipid metabolic process |
GO:0014074 |
3.88% |
response to purine-containing compound |
GO:0050730 |
3.87% |
regulation of peptidyl-tyrosine phosphorylation |
GO:0043393 |
3.87% |
regulation of protein binding |
GO:0042060 |
3.87% |
wound healing |
GO:0008217 |
3.87% |
regulation of blood pressure |
GO:0032981 |
3.87% |
mitochondrial respiratory chain complex I assembly |
GO:1900408 |
3.86% |
negative regulation of cellular response to oxidative stress |
GO:0044087 |
3.85% |
regulation of cellular component biogenesis |
GO:1901099 |
3.85% |
negative regulation of signal transduction in absence of ligand |
GO:0034284 |
3.84% |
response to monosaccharide |
GO:0014065 |
3.84% |
phosphatidylinositol 3-kinase signaling |
GO:0002460 |
3.84% |
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0003013 |
3.84% |
circulatory system process |
GO:0010906 |
3.84% |
regulation of glucose metabolic process |
GO:0016310 |
3.83% |
phosphorylation |
GO:0003012 |
3.83% |
muscle system process |
GO:0010810 |
3.79% |
regulation of cell-substrate adhesion |
GO:0009968 |
3.79% |
negative regulation of signal transduction |
GO:1901987 |
3.78% |
regulation of cell cycle phase transition |
GO:2001039 |
3.78% |
negative regulation of cellular response to drug |
GO:0009792 |
3.78% |
embryo development ending in birth or egg hatching |
GO:0019218 |
3.77% |
regulation of steroid metabolic process |
GO:0030097 |
3.76% |
hemopoiesis |
GO:0044089 |
3.76% |
positive regulation of cellular component biogenesis |
GO:0050878 |
3.76% |
regulation of body fluid levels |
GO:0048521 |
3.76% |
negative regulation of behavior |
GO:0090066 |
3.75% |
regulation of anatomical structure size |
GO:0034249 |
3.74% |
negative regulation of cellular amide metabolic process |
GO:0033043 |
3.74% |
regulation of organelle organization |
GO:0009746 |
3.73% |
response to hexose |
GO:0022610 |
3.73% |
biological adhesion |
GO:0043627 |
3.71% |
response to estrogen |
GO:0034622 |
3.71% |
cellular protein-containing complex assembly |
GO:0022900 |
3.70% |
electron transport chain |
GO:0046620 |
3.70% |
regulation of organ growth |
GO:0002784 |
3.70% |
regulation of antimicrobial peptide production |
GO:0051896 |
3.69% |
regulation of protein kinase B signaling |
GO:0061024 |
3.68% |
membrane organization |
GO:0090659 |
3.68% |
walking behavior |
GO:0051817 |
3.68% |
modification of morphology or physiology of other organism involved in symbiotic interaction |
GO:0042445 |
3.67% |
hormone metabolic process |
GO:0030278 |
3.67% |
regulation of ossification |
GO:0010950 |
3.67% |
positive regulation of endopeptidase activity |
GO:0043900 |
3.67% |
regulation of multi-organism process |
GO:0006351 |
3.66% |
transcription, DNA-templated |
GO:0033273 |
3.66% |
response to vitamin |
GO:0040013 |
3.65% |
negative regulation of locomotion |
GO:1901699 |
3.65% |
cellular response to nitrogen compound |
GO:0051345 |
3.65% |
positive regulation of hydrolase activity |
GO:0045596 |
3.64% |
negative regulation of cell differentiation |
GO:0071482 |
3.64% |
cellular response to light stimulus |
GO:0046903 |
3.63% |
secretion |
GO:0002700 |
3.63% |
regulation of production of molecular mediator of immune response |
GO:2001056 |
3.62% |
positive regulation of cysteine-type endopeptidase activity |
GO:0061013 |
3.62% |
regulation of mRNA catabolic process |
GO:0030098 |
3.62% |
lymphocyte differentiation |
GO:2001240 |
3.62% |
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0031670 |
3.62% |
cellular response to nutrient |
GO:0051702 |
3.62% |
interaction with symbiont |
GO:0043280 |
3.62% |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0051607 |
3.60% |
defense response to virus |
GO:0010821 |
3.59% |
regulation of mitochondrion organization |
GO:0097659 |
3.59% |
nucleic acid-templated transcription |
GO:0033138 |
3.59% |
positive regulation of peptidyl-serine phosphorylation |
GO:0030334 |
3.59% |
regulation of cell migration |
GO:0030856 |
3.59% |
regulation of epithelial cell differentiation |
GO:0051098 |
3.59% |
regulation of binding |
GO:1902882 |
3.59% |
regulation of response to oxidative stress |
GO:0043487 |
3.58% |
regulation of RNA stability |
GO:0009615 |
3.58% |
response to virus |
GO:0051412 |
3.57% |
response to corticosterone |
GO:0019725 |
3.57% |
cellular homeostasis |
GO:0009058 |
3.57% |
biosynthetic process |
GO:0032091 |
3.57% |
negative regulation of protein binding |
GO:0040012 |
3.56% |
regulation of locomotion |
GO:0097191 |
3.55% |
extrinsic apoptotic signaling pathway |
GO:2001236 |
3.55% |
regulation of extrinsic apoptotic signaling pathway |
GO:0050731 |
3.54% |
positive regulation of peptidyl-tyrosine phosphorylation |
GO:2000145 |
3.54% |
regulation of cell motility |
GO:1902532 |
3.54% |
negative regulation of intracellular signal transduction |
GO:0001525 |
3.54% |
angiogenesis |
GO:1900117 |
3.54% |
regulation of execution phase of apoptosis |
GO:0021987 |
3.53% |
cerebral cortex development |
GO:0001541 |
3.53% |
ovarian follicle development |
GO:0071695 |
3.52% |
anatomical structure maturation |
GO:0009749 |
3.52% |
response to glucose |
GO:1903311 |
3.52% |
regulation of mRNA metabolic process |
GO:2001239 |
3.51% |
regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0007155 |
3.50% |
cell adhesion |
GO:0022604 |
3.50% |
regulation of cell morphogenesis |
GO:0010758 |
3.49% |
regulation of macrophage chemotaxis |
GO:0033500 |
3.49% |
carbohydrate homeostasis |
GO:1904018 |
3.49% |
positive regulation of vasculature development |
GO:1902883 |
3.49% |
negative regulation of response to oxidative stress |
GO:0055093 |
3.49% |
response to hyperoxia |
GO:1903998 |
3.48% |
regulation of eating behavior |
GO:0051781 |
3.48% |
positive regulation of cell division |
GO:0007346 |
3.48% |
regulation of mitotic cell cycle |
GO:0044260 |
3.48% |
cellular macromolecule metabolic process |
GO:0071346 |
3.47% |
cellular response to interferon-gamma |
GO:0010811 |
3.47% |
positive regulation of cell-substrate adhesion |
GO:0001818 |
3.47% |
negative regulation of cytokine production |
GO:0008637 |
3.47% |
apoptotic mitochondrial changes |
GO:0030218 |
3.47% |
erythrocyte differentiation |
GO:0048666 |
3.46% |
neuron development |
GO:0046683 |
3.46% |
response to organophosphorus |
GO:0033189 |
3.46% |
response to vitamin A |
GO:0007628 |
3.45% |
adult walking behavior |
GO:0007565 |
3.45% |
female pregnancy |
GO:0048580 |
3.44% |
regulation of post-embryonic development |
GO:0010565 |
3.44% |
regulation of cellular ketone metabolic process |
GO:0050680 |
3.44% |
negative regulation of epithelial cell proliferation |
GO:2000648 |
3.43% |
positive regulation of stem cell proliferation |
GO:0042403 |
3.43% |
thyroid hormone metabolic process |
GO:0035902 |
3.42% |
response to immobilization stress |
GO:0034248 |
3.42% |
regulation of cellular amide metabolic process |
GO:1903429 |
3.42% |
regulation of cell maturation |
GO:0032755 |
3.42% |
positive regulation of interleukin-6 production |
GO:2001023 |
3.42% |
regulation of response to drug |
GO:1902806 |
3.40% |
regulation of cell cycle G1/S phase transition |
GO:0044255 |
3.39% |
cellular lipid metabolic process |
GO:0050953 |
3.39% |
sensory perception of light stimulus |
GO:0031175 |
3.39% |
neuron projection development |
GO:0010257 |
3.39% |
NADH dehydrogenase complex assembly |
GO:0072091 |
3.38% |
regulation of stem cell proliferation |
GO:0001822 |
3.38% |
kidney development |
GO:0033674 |
3.38% |
positive regulation of kinase activity |
GO:0007586 |
3.38% |
digestion |
GO:0071827 |
3.38% |
plasma lipoprotein particle organization |
GO:0002761 |
3.38% |
regulation of myeloid leukocyte differentiation |
GO:0010639 |
3.37% |
negative regulation of organelle organization |
GO:0032642 |
3.37% |
regulation of chemokine production |
GO:0031589 |
3.37% |
cell-substrate adhesion |
GO:0008610 |
3.37% |
lipid biosynthetic process |
GO:0048520 |
3.36% |
positive regulation of behavior |
GO:0062013 |
3.36% |
positive regulation of small molecule metabolic process |
GO:0098781 |
3.36% |
ncRNA transcription |
GO:0043488 |
3.36% |
regulation of mRNA stability |
GO:0002251 |
3.36% |
organ or tissue specific immune response |
GO:0051049 |
3.36% |
regulation of transport |
GO:0045766 |
3.36% |
positive regulation of angiogenesis |
GO:0070584 |
3.35% |
mitochondrion morphogenesis |
GO:0051897 |
3.35% |
positive regulation of protein kinase B signaling |
GO:0008625 |
3.35% |
extrinsic apoptotic signaling pathway via death domain receptors |
GO:2000573 |
3.35% |
positive regulation of DNA biosynthetic process |
GO:0051592 |
3.35% |
response to calcium ion |
GO:0036296 |
3.35% |
response to increased oxygen levels |
GO:0010634 |
3.35% |
positive regulation of epithelial cell migration |
GO:0061458 |
3.34% |
reproductive system development |
GO:0043902 |
3.34% |
positive regulation of multi-organism process |
GO:0043009 |
3.34% |
chordate embryonic development |
GO:0050994 |
3.34% |
regulation of lipid catabolic process |
GO:0032675 |
3.34% |
regulation of interleukin-6 production |
GO:0007589 |
3.34% |
body fluid secretion |
GO:2000146 |
3.34% |
negative regulation of cell motility |
GO:0045661 |
3.33% |
regulation of myoblast differentiation |
GO:0061138 |
3.32% |
morphogenesis of a branching epithelium |
GO:0007422 |
3.32% |
peripheral nervous system development |
GO:0051270 |
3.32% |
regulation of cellular component movement |
GO:0120161 |
3.32% |
regulation of cold-induced thermogenesis |
GO:0043401 |
3.32% |
steroid hormone mediated signaling pathway |
GO:0002920 |
3.32% |
regulation of humoral immune response |
GO:0007601 |
3.30% |
visual perception |
GO:1900076 |
3.30% |
regulation of cellular response to insulin stimulus |
GO:1903034 |
3.30% |
regulation of response to wounding |
GO:0034341 |
3.30% |
response to interferon-gamma |
GO:0007338 |
3.30% |
single fertilization |
GO:0070542 |
3.30% |
response to fatty acid |
GO:0033135 |
3.29% |
regulation of peptidyl-serine phosphorylation |
GO:0001763 |
3.29% |
morphogenesis of a branching structure |
GO:0009914 |
3.29% |
hormone transport |
GO:0046879 |
3.29% |
hormone secretion |
GO:0010675 |
3.28% |
regulation of cellular carbohydrate metabolic process |
GO:0051253 |
3.27% |
negative regulation of RNA metabolic process |
GO:0048660 |
3.26% |
regulation of smooth muscle cell proliferation |
GO:0010507 |
3.26% |
negative regulation of autophagy |
GO:0045940 |
3.26% |
positive regulation of steroid metabolic process |
GO:0048015 |
3.26% |
phosphatidylinositol-mediated signaling |
GO:0006582 |
3.26% |
melanin metabolic process |
GO:0002759 |
3.26% |
regulation of antimicrobial humoral response |
GO:0033032 |
3.26% |
regulation of myeloid cell apoptotic process |
GO:0042593 |
3.26% |
glucose homeostasis |
GO:0009791 |
3.26% |
post-embryonic development |
GO:0032940 |
3.26% |
secretion by cell |
GO:0042531 |
3.25% |
positive regulation of tyrosine phosphorylation of STAT protein |
GO:0044249 |
3.25% |
cellular biosynthetic process |
GO:0001709 |
3.23% |
cell fate determination |
GO:0051260 |
3.23% |
protein homooligomerization |
GO:0032760 |
3.23% |
positive regulation of tumor necrosis factor production |
GO:0007606 |
3.23% |
sensory perception of chemical stimulus |
GO:0042509 |
3.23% |
regulation of tyrosine phosphorylation of STAT protein |
GO:0030879 |
3.22% |
mammary gland development |
GO:2000045 |
3.21% |
regulation of G1/S transition of mitotic cell cycle |
GO:0010893 |
3.21% |
positive regulation of steroid biosynthetic process |
GO:0017144 |
3.20% |
drug metabolic process |
GO:0014823 |
3.20% |
response to activity |
GO:0051271 |
3.20% |
negative regulation of cellular component movement |
GO:0045860 |
3.20% |
positive regulation of protein kinase activity |
GO:0030030 |
3.20% |
cell projection organization |
GO:1901990 |
3.19% |
regulation of mitotic cell cycle phase transition |
GO:0007612 |
3.19% |
learning |
GO:2000379 |
3.19% |
positive regulation of reactive oxygen species metabolic process |
GO:0098743 |
3.19% |
cell aggregation |
GO:0045598 |
3.18% |
regulation of fat cell differentiation |
GO:0030518 |
3.18% |
intracellular steroid hormone receptor signaling pathway |
GO:0010632 |
3.18% |
regulation of epithelial cell migration |
GO:0043200 |
3.18% |
response to amino acid |
GO:0120162 |
3.17% |
positive regulation of cold-induced thermogenesis |
GO:0042440 |
3.17% |
pigment metabolic process |
GO:0002250 |
3.17% |
adaptive immune response |
GO:2000243 |
3.16% |
positive regulation of reproductive process |
GO:0055088 |
3.16% |
lipid homeostasis |
GO:1903708 |
3.16% |
positive regulation of hemopoiesis |
GO:0040018 |
3.16% |
positive regulation of multicellular organism growth |
GO:0043405 |
3.16% |
regulation of MAP kinase activity |
GO:0006970 |
3.15% |
response to osmotic stress |
GO:0043467 |
3.14% |
regulation of generation of precursor metabolites and energy |
GO:1901575 |
3.14% |
organic substance catabolic process |
GO:0090501 |
3.13% |
RNA phosphodiester bond hydrolysis |
GO:0070848 |
3.13% |
response to growth factor |
GO:0002639 |
3.12% |
positive regulation of immunoglobulin production |
GO:0001503 |
3.11% |
ossification |
GO:0071407 |
3.11% |
cellular response to organic cyclic compound |
GO:0032774 |
3.11% |
RNA biosynthetic process |
GO:0034655 |
3.10% |
nucleobase-containing compound catabolic process |
GO:0051051 |
3.10% |
negative regulation of transport |
GO:0002697 |
3.10% |
regulation of immune effector process |
GO:2001234 |
3.09% |
negative regulation of apoptotic signaling pathway |
GO:0051851 |
3.09% |
modification by host of symbiont morphology or physiology |
GO:2000105 |
3.09% |
positive regulation of DNA-dependent DNA replication |
GO:0043901 |
3.08% |
negative regulation of multi-organism process |
GO:0048640 |
3.08% |
negative regulation of developmental growth |
GO:0090287 |
3.08% |
regulation of cellular response to growth factor stimulus |
GO:0032104 |
3.08% |
regulation of response to extracellular stimulus |
GO:0045777 |
3.08% |
positive regulation of blood pressure |
GO:0032965 |
3.07% |
regulation of collagen biosynthetic process |
GO:0006909 |
3.07% |
phagocytosis |
GO:0018209 |
3.07% |
peptidyl-serine modification |
GO:0045839 |
3.07% |
negative regulation of mitotic nuclear division |
GO:0051092 |
3.06% |
positive regulation of NF-kappaB transcription factor activity |
GO:0014068 |
3.06% |
positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0072331 |
3.06% |
signal transduction by p53 class mediator |
GO:0071322 |
3.06% |
cellular response to carbohydrate stimulus |
GO:0002922 |
3.05% |
positive regulation of humoral immune response |
GO:0038034 |
3.05% |
signal transduction in absence of ligand |
GO:0042119 |
3.05% |
neutrophil activation |
GO:0001667 |
3.05% |
ameboidal-type cell migration |
GO:1901532 |
3.05% |
regulation of hematopoietic progenitor cell differentiation |
GO:0014066 |
3.04% |
regulation of phosphatidylinositol 3-kinase signaling |
GO:2001024 |
3.04% |
negative regulation of response to drug |
GO:0051186 |
3.04% |
cofactor metabolic process |
GO:0043062 |
3.04% |
extracellular structure organization |
GO:0097192 |
3.04% |
extrinsic apoptotic signaling pathway in absence of ligand |
GO:0009409 |
3.03% |
response to cold |
GO:0030336 |
3.03% |
negative regulation of cell migration |
GO:0097193 |
3.03% |
intrinsic apoptotic signaling pathway |
GO:0071260 |
3.02% |
cellular response to mechanical stimulus |
GO:0010039 |
3.02% |
response to iron ion |
GO:0032107 |
3.02% |
regulation of response to nutrient levels |
GO:1904407 |
3.01% |
positive regulation of nitric oxide metabolic process |
GO:0120036 |
3.01% |
plasma membrane bounded cell projection organization |
GO:0046889 |
3.01% |
positive regulation of lipid biosynthetic process |
GO:0006793 |
3.01% |
phosphorus metabolic process |
GO:0030858 |
3.01% |
positive regulation of epithelial cell differentiation |
GO:0034605 |
3.00% |
cellular response to heat |
GO:0071702 |
3.00% |
organic substance transport |
GO:0010638 |
3.00% |
positive regulation of organelle organization |
GO:0051046 |
2.99% |
regulation of secretion |
GO:0090559 |
2.99% |
regulation of membrane permeability |
GO:0001678 |
2.98% |
cellular glucose homeostasis |
GO:0010677 |
2.98% |
negative regulation of cellular carbohydrate metabolic process |
GO:0045619 |
2.98% |
regulation of lymphocyte differentiation |
GO:0098916 |
2.98% |
anterograde trans-synaptic signaling |
GO:1905521 |
2.98% |
regulation of macrophage migration |
GO:0034368 |
2.95% |
protein-lipid complex remodeling |
GO:0042100 |
2.95% |
B cell proliferation |
GO:0006721 |
2.94% |
terpenoid metabolic process |
GO:0045833 |
2.94% |
negative regulation of lipid metabolic process |
GO:0070098 |
2.94% |
chemokine-mediated signaling pathway |
GO:0071333 |
2.94% |
cellular response to glucose stimulus |
GO:0022612 |
2.94% |
gland morphogenesis |
GO:0048641 |
2.94% |
regulation of skeletal muscle tissue development |
GO:0030198 |
2.94% |
extracellular matrix organization |
GO:0006796 |
2.93% |
phosphate-containing compound metabolic process |
GO:0030855 |
2.93% |
epithelial cell differentiation |
GO:0048729 |
2.92% |
tissue morphogenesis |
GO:0051100 |
2.92% |
negative regulation of binding |
GO:0140352 |
2.91% |
export from cell |
GO:1901576 |
2.91% |
organic substance biosynthetic process |
GO:0071479 |
2.91% |
cellular response to ionizing radiation |
GO:0055090 |
2.90% |
acylglycerol homeostasis |
GO:0010714 |
2.90% |
positive regulation of collagen metabolic process |
GO:1902369 |
2.90% |
negative regulation of RNA catabolic process |
GO:0045923 |
2.90% |
positive regulation of fatty acid metabolic process |
GO:0048568 |
2.89% |
embryonic organ development |
GO:0008306 |
2.89% |
associative learning |
GO:0036230 |
2.88% |
granulocyte activation |
GO:0002637 |
2.88% |
regulation of immunoglobulin production |
GO:0062014 |
2.87% |
negative regulation of small molecule metabolic process |
GO:0043123 |
2.87% |
positive regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0070328 |
2.87% |
triglyceride homeostasis |
GO:0007389 |
2.86% |
pattern specification process |
GO:0099537 |
2.86% |
trans-synaptic signaling |
GO:0071230 |
2.86% |
cellular response to amino acid stimulus |
GO:0050777 |
2.85% |
negative regulation of immune response |
GO:0043032 |
2.85% |
positive regulation of macrophage activation |
GO:0042330 |
2.85% |
taxis |
GO:1903672 |
2.85% |
positive regulation of sprouting angiogenesis |
GO:0019722 |
2.84% |
calcium-mediated signaling |
GO:0019439 |
2.83% |
aromatic compound catabolic process |
GO:0001523 |
2.83% |
retinoid metabolic process |
GO:0032653 |
2.83% |
regulation of interleukin-10 production |
GO:0008340 |
2.82% |
determination of adult lifespan |
GO:0010822 |
2.81% |
positive regulation of mitochondrion organization |
GO:0046686 |
2.81% |
response to cadmium ion |
GO:0051289 |
2.80% |
protein homotetramerization |
GO:0007268 |
2.80% |
chemical synaptic transmission |
GO:0044265 |
2.80% |
cellular macromolecule catabolic process |
GO:0048598 |
2.80% |
embryonic morphogenesis |
GO:0051259 |
2.79% |
protein complex oligomerization |
GO:0043271 |
2.79% |
negative regulation of ion transport |
GO:0090200 |
2.79% |
positive regulation of release of cytochrome c from mitochondria |
GO:0051050 |
2.79% |
positive regulation of transport |
GO:0061041 |
2.78% |
regulation of wound healing |
GO:1901361 |
2.78% |
organic cyclic compound catabolic process |
GO:0015850 |
2.77% |
organic hydroxy compound transport |
GO:0007608 |
2.76% |
sensory perception of smell |
GO:0042417 |
2.76% |
dopamine metabolic process |
GO:0045646 |
2.76% |
regulation of erythrocyte differentiation |
GO:0007399 |
2.76% |
nervous system development |
GO:1990830 |
2.75% |
cellular response to leukemia inhibitory factor |
GO:0070661 |
2.75% |
leukocyte proliferation |
GO:0042136 |
2.75% |
neurotransmitter biosynthetic process |
GO:0032990 |
2.75% |
cell part morphogenesis |
GO:0034369 |
2.75% |
plasma lipoprotein particle remodeling |
GO:0045892 |
2.75% |
negative regulation of transcription, DNA-templated |
GO:1903507 |
2.74% |
negative regulation of nucleic acid-templated transcription |
GO:0045454 |
2.74% |
cell redox homeostasis |
GO:0050776 |
2.74% |
regulation of immune response |
GO:0009629 |
2.74% |
response to gravity |
GO:0006120 |
2.74% |
mitochondrial electron transport, NADH to ubiquinone |
GO:1903427 |
2.73% |
negative regulation of reactive oxygen species biosynthetic process |
GO:1902679 |
2.73% |
negative regulation of RNA biosynthetic process |
GO:0032733 |
2.73% |
positive regulation of interleukin-10 production |
GO:0001505 |
2.73% |
regulation of neurotransmitter levels |
GO:0006869 |
2.73% |
lipid transport |
GO:2001238 |
2.72% |
positive regulation of extrinsic apoptotic signaling pathway |
GO:0000902 |
2.72% |
cell morphogenesis |
GO:0009303 |
2.72% |
rRNA transcription |
GO:1900015 |
2.72% |
regulation of cytokine production involved in inflammatory response |
GO:0050864 |
2.72% |
regulation of B cell activation |
GO:0032526 |
2.72% |
response to retinoic acid |
GO:0008630 |
2.71% |
intrinsic apoptotic signaling pathway in response to DNA damage |
GO:1902692 |
2.71% |
regulation of neuroblast proliferation |
GO:0016101 |
2.71% |
diterpenoid metabolic process |
GO:1901362 |
2.71% |
organic cyclic compound biosynthetic process |
GO:0010224 |
2.70% |
response to UV-B |
GO:0001701 |
2.70% |
in utero embryonic development |
GO:0097164 |
2.70% |
ammonium ion metabolic process |
GO:0071331 |
2.68% |
cellular response to hexose stimulus |
GO:0033108 |
2.68% |
mitochondrial respiratory chain complex assembly |
GO:0010595 |
2.68% |
positive regulation of endothelial cell migration |
GO:0016485 |
2.68% |
protein processing |
GO:0051604 |
2.68% |
protein maturation |
GO:0070633 |
2.67% |
transepithelial transport |
GO:0032651 |
2.67% |
regulation of interleukin-1 beta production |
GO:0032570 |
2.67% |
response to progesterone |
GO:0071772 |
2.66% |
response to BMP |
GO:0006811 |
2.66% |
ion transport |
GO:0071825 |
2.66% |
protein-lipid complex subunit organization |
GO:0043470 |
2.65% |
regulation of carbohydrate catabolic process |
GO:0007595 |
2.64% |
lactation |
GO:0060627 |
2.64% |
regulation of vesicle-mediated transport |
GO:0051641 |
2.64% |
cellular localization |
GO:0099536 |
2.64% |
synaptic signaling |
GO:0016071 |
2.64% |
mRNA metabolic process |
GO:0061077 |
2.64% |
chaperone-mediated protein folding |
GO:0044281 |
2.64% |
small molecule metabolic process |
GO:0071773 |
2.63% |
cellular response to BMP stimulus |
GO:0042113 |
2.63% |
B cell activation |
GO:0051258 |
2.63% |
protein polymerization |
GO:0051055 |
2.63% |
negative regulation of lipid biosynthetic process |
GO:0044270 |
2.63% |
cellular nitrogen compound catabolic process |
GO:1903362 |
2.63% |
regulation of cellular protein catabolic process |
GO:0045577 |
2.63% |
regulation of B cell differentiation |
GO:0034367 |
2.63% |
protein-containing complex remodeling |
GO:1903426 |
2.63% |
regulation of reactive oxygen species biosynthetic process |
GO:0007613 |
2.62% |
memory |
GO:0030155 |
2.62% |
regulation of cell adhesion |
GO:0050900 |
2.62% |
leukocyte migration |
GO:0071326 |
2.62% |
cellular response to monosaccharide stimulus |
GO:0032967 |
2.62% |
positive regulation of collagen biosynthetic process |
GO:0006401 |
2.61% |
RNA catabolic process |
GO:0033344 |
2.61% |
cholesterol efflux |
GO:0050873 |
2.61% |
brown fat cell differentiation |
GO:0043122 |
2.61% |
regulation of I-kappaB kinase/NF-kappaB signaling |
GO:1901565 |
2.60% |
organonitrogen compound catabolic process |
GO:2001020 |
2.60% |
regulation of response to DNA damage stimulus |
GO:2000027 |
2.60% |
regulation of animal organ morphogenesis |
GO:0006935 |
2.59% |
chemotaxis |
GO:0023061 |
2.59% |
signal release |
GO:0048582 |
2.58% |
positive regulation of post-embryonic development |
GO:0051147 |
2.58% |
regulation of muscle cell differentiation |
GO:0051053 |
2.58% |
negative regulation of DNA metabolic process |
GO:0050807 |
2.58% |
regulation of synapse organization |
GO:0065005 |
2.58% |
protein-lipid complex assembly |
GO:1901861 |
2.57% |
regulation of muscle tissue development |
GO:0002262 |
2.57% |
myeloid cell homeostasis |
GO:0030308 |
2.56% |
negative regulation of cell growth |
GO:0002227 |
2.56% |
innate immune response in mucosa |
GO:0044271 |
2.55% |
cellular nitrogen compound biosynthetic process |
GO:2000378 |
2.55% |
negative regulation of reactive oxygen species metabolic process |
GO:0040017 |
2.55% |
positive regulation of locomotion |
GO:0019827 |
2.54% |
stem cell population maintenance |
GO:0043603 |
2.54% |
cellular amide metabolic process |
GO:0019217 |
2.54% |
regulation of fatty acid metabolic process |
GO:0045912 |
2.54% |
negative regulation of carbohydrate metabolic process |
GO:0044267 |
2.54% |
cellular protein metabolic process |
GO:0046700 |
2.54% |
heterocycle catabolic process |
GO:0051705 |
2.54% |
multi-organism behavior |
GO:0002573 |
2.53% |
myeloid leukocyte differentiation |
GO:0010594 |
2.53% |
regulation of endothelial cell migration |
GO:0098609 |
2.53% |
cell-cell adhesion |
GO:0045475 |
2.53% |
locomotor rhythm |
GO:0002673 |
2.53% |
regulation of acute inflammatory response |
GO:0019748 |
2.52% |
secondary metabolic process |
GO:1905332 |
2.52% |
positive regulation of morphogenesis of an epithelium |
GO:0030431 |
2.51% |
sleep |
GO:0001562 |
2.51% |
response to protozoan |
GO:0045995 |
2.51% |
regulation of embryonic development |
GO:0009057 |
2.50% |
macromolecule catabolic process |
GO:0048873 |
2.50% |
homeostasis of number of cells within a tissue |
GO:0045663 |
2.50% |
positive regulation of myoblast differentiation |
GO:0002763 |
2.50% |
positive regulation of myeloid leukocyte differentiation |
GO:0006936 |
2.50% |
muscle contraction |
GO:0043567 |
2.50% |
regulation of insulin-like growth factor receptor signaling pathway |
GO:0002385 |
2.49% |
mucosal immune response |
GO:0071363 |
2.49% |
cellular response to growth factor stimulus |
GO:0002009 |
2.49% |
morphogenesis of an epithelium |
GO:0010939 |
2.49% |
regulation of necrotic cell death |
GO:0050801 |
2.49% |
ion homeostasis |
GO:2000147 |
2.48% |
positive regulation of cell motility |
GO:0032652 |
2.48% |
regulation of interleukin-1 production |
GO:0032418 |
2.48% |
lysosome localization |
GO:0072332 |
2.47% |
intrinsic apoptotic signaling pathway by p53 class mediator |
GO:0006383 |
2.47% |
transcription by RNA polymerase III |
GO:0030183 |
2.47% |
B cell differentiation |
GO:0030888 |
2.47% |
regulation of B cell proliferation |
GO:0006720 |
2.47% |
isoprenoid metabolic process |
GO:0090199 |
2.46% |
regulation of release of cytochrome c from mitochondria |
GO:0009744 |
2.46% |
response to sucrose |
GO:0006099 |
2.45% |
tricarboxylic acid cycle |
GO:0097327 |
2.45% |
response to antineoplastic agent |
GO:1903578 |
2.45% |
regulation of ATP metabolic process |
GO:0030335 |
2.45% |
positive regulation of cell migration |
GO:0045670 |
2.45% |
regulation of osteoclast differentiation |
GO:0097306 |
2.45% |
cellular response to alcohol |
GO:0034660 |
2.44% |
ncRNA metabolic process |
GO:0071392 |
2.44% |
cellular response to estradiol stimulus |
GO:0001570 |
2.44% |
vasculogenesis |
GO:0048563 |
2.44% |
post-embryonic animal organ morphogenesis |
GO:0003018 |
2.44% |
vascular process in circulatory system |
GO:0045682 |
2.44% |
regulation of epidermis development |
GO:0050871 |
2.43% |
positive regulation of B cell activation |
GO:1903580 |
2.42% |
positive regulation of ATP metabolic process |
GO:0006140 |
2.42% |
regulation of nucleotide metabolic process |
GO:0048538 |
2.42% |
thymus development |
GO:0070925 |
2.42% |
organelle assembly |
GO:1900542 |
2.42% |
regulation of purine nucleotide metabolic process |
GO:0022402 |
2.42% |
cell cycle process |
GO:2001242 |
2.41% |
regulation of intrinsic apoptotic signaling pathway |
GO:1903707 |
2.41% |
negative regulation of hemopoiesis |
GO:0002831 |
2.41% |
regulation of response to biotic stimulus |
GO:0030301 |
2.41% |
cholesterol transport |
GO:1902106 |
2.41% |
negative regulation of leukocyte differentiation |
GO:0003254 |
2.41% |
regulation of membrane depolarization |
GO:0018130 |
2.41% |
heterocycle biosynthetic process |
GO:0050778 |
2.41% |
positive regulation of immune response |
GO:0050920 |
2.41% |
regulation of chemotaxis |
GO:1900120 |
2.41% |
regulation of receptor binding |
GO:0042304 |
2.40% |
regulation of fatty acid biosynthetic process |
GO:0071384 |
2.40% |
cellular response to corticosteroid stimulus |
GO:0071674 |
2.40% |
mononuclear cell migration |
GO:0000003 |
2.39% |
reproduction |
GO:0045165 |
2.39% |
cell fate commitment |
GO:0071705 |
2.39% |
nitrogen compound transport |
GO:0090257 |
2.38% |
regulation of muscle system process |
GO:0002861 |
2.38% |
regulation of inflammatory response to antigenic stimulus |
GO:0030330 |
2.37% |
DNA damage response, signal transduction by p53 class mediator |
GO:0010001 |
2.37% |
glial cell differentiation |
GO:0048754 |
2.37% |
branching morphogenesis of an epithelial tube |
GO:0051402 |
2.36% |
neuron apoptotic process |
GO:0007168 |
2.36% |
receptor guanylyl cyclase signaling pathway |
GO:0051216 |
2.36% |
cartilage development |
GO:0001649 |
2.36% |
osteoblast differentiation |
GO:0090398 |
2.36% |
cellular senescence |
GO:0016202 |
2.36% |
regulation of striated muscle tissue development |
GO:0022411 |
2.35% |
cellular component disassembly |
GO:0006259 |
2.35% |
DNA metabolic process |
GO:0008543 |
2.35% |
fibroblast growth factor receptor signaling pathway |
GO:2000106 |
2.35% |
regulation of leukocyte apoptotic process |
GO:0097485 |
2.34% |
neuron projection guidance |
GO:0097722 |
2.34% |
sperm motility |
GO:1990823 |
2.34% |
response to leukemia inhibitory factor |
GO:0071383 |
2.34% |
cellular response to steroid hormone stimulus |
GO:2000058 |
2.34% |
regulation of ubiquitin-dependent protein catabolic process |
GO:1902117 |
2.33% |
positive regulation of organelle assembly |
GO:0006518 |
2.33% |
peptide metabolic process |
GO:0035265 |
2.32% |
organ growth |
GO:0030101 |
2.32% |
natural killer cell activation |
GO:0050905 |
2.32% |
neuromuscular process |
GO:0034661 |
2.32% |
ncRNA catabolic process |
GO:1901653 |
2.32% |
cellular response to peptide |
GO:0051272 |
2.32% |
positive regulation of cellular component movement |
GO:0016192 |
2.31% |
vesicle-mediated transport |
GO:0010743 |
2.31% |
regulation of macrophage derived foam cell differentiation |
GO:0071241 |
2.31% |
cellular response to inorganic substance |
GO:0048562 |
2.31% |
embryonic organ morphogenesis |
GO:1903036 |
2.31% |
positive regulation of response to wounding |
GO:0002065 |
2.31% |
columnar/cuboidal epithelial cell differentiation |
GO:0060285 |
2.30% |
cilium-dependent cell motility |
GO:0098727 |
2.30% |
maintenance of cell number |
GO:2001244 |
2.30% |
positive regulation of intrinsic apoptotic signaling pathway |
GO:0030857 |
2.30% |
negative regulation of epithelial cell differentiation |
GO:0003002 |
2.30% |
regionalization |
GO:0071385 |
2.30% |
cellular response to glucocorticoid stimulus |
GO:0045913 |
2.29% |
positive regulation of carbohydrate metabolic process |
GO:1905952 |
2.29% |
regulation of lipid localization |
GO:0007006 |
2.28% |
mitochondrial membrane organization |
GO:0035150 |
2.28% |
regulation of tube size |
GO:1905954 |
2.28% |
positive regulation of lipid localization |
GO:0042110 |
2.28% |
T cell activation |
GO:0032943 |
2.28% |
mononuclear cell proliferation |
GO:0060261 |
2.28% |
positive regulation of transcription initiation from RNA polymerase II promoter |
GO:0071548 |
2.28% |
response to dexamethasone |
GO:0046651 |
2.28% |
lymphocyte proliferation |
GO:0045600 |
2.27% |
positive regulation of fat cell differentiation |
GO:0048634 |
2.27% |
regulation of muscle organ development |
GO:0019932 |
2.26% |
second-messenger-mediated signaling |
GO:0008347 |
2.26% |
glial cell migration |
GO:0002437 |
2.26% |
inflammatory response to antigenic stimulus |
GO:0045742 |
2.26% |
positive regulation of epidermal growth factor receptor signaling pathway |
GO:0090303 |
2.26% |
positive regulation of wound healing |
GO:0042552 |
2.25% |
myelination |
GO:0007015 |
2.25% |
actin filament organization |
GO:0010770 |
2.25% |
positive regulation of cell morphogenesis involved in differentiation |
GO:0009712 |
2.25% |
catechol-containing compound metabolic process |
GO:0019438 |
2.25% |
aromatic compound biosynthetic process |
GO:0071320 |
2.24% |
cellular response to cAMP |
GO:0071774 |
2.24% |
response to fibroblast growth factor |
GO:0010830 |
2.24% |
regulation of myotube differentiation |
GO:0046148 |
2.24% |
pigment biosynthetic process |
GO:0002548 |
2.24% |
monocyte chemotaxis |
GO:0051640 |
2.23% |
organelle localization |
GO:0034285 |
2.23% |
response to disaccharide |
GO:0010721 |
2.23% |
negative regulation of cell development |
GO:0051262 |
2.23% |
protein tetramerization |
GO:1901186 |
2.22% |
positive regulation of ERBB signaling pathway |
GO:0051926 |
2.22% |
negative regulation of calcium ion transport |
GO:0007411 |
2.22% |
axon guidance |
GO:0010665 |
2.22% |
regulation of cardiac muscle cell apoptotic process |
GO:0000904 |
2.22% |
cell morphogenesis involved in differentiation |
GO:0097028 |
2.22% |
dendritic cell differentiation |
GO:0110110 |
2.21% |
positive regulation of animal organ morphogenesis |
GO:0042755 |
2.20% |
eating behavior |
GO:0051656 |
2.20% |
establishment of organelle localization |
GO:0010469 |
2.20% |
regulation of signaling receptor activity |
GO:1903725 |
2.20% |
regulation of phospholipid metabolic process |
GO:0008202 |
2.20% |
steroid metabolic process |
GO:0071559 |
2.20% |
response to transforming growth factor beta |
GO:0032006 |
2.19% |
regulation of TOR signaling |
GO:0045776 |
2.19% |
negative regulation of blood pressure |
GO:0006464 |
2.19% |
cellular protein modification process |
GO:0036211 |
2.19% |
protein modification process |
GO:1905330 |
2.19% |
regulation of morphogenesis of an epithelium |
GO:0006575 |
2.19% |
cellular modified amino acid metabolic process |
GO:0030317 |
2.19% |
flagellated sperm motility |
GO:0032731 |
2.18% |
positive regulation of interleukin-1 beta production |
GO:0032673 |
2.18% |
regulation of interleukin-4 production |
GO:0040019 |
2.18% |
positive regulation of embryonic development |
GO:0032147 |
2.18% |
activation of protein kinase activity |
GO:0031333 |
2.18% |
negative regulation of protein complex assembly |
GO:0042770 |
2.18% |
signal transduction in response to DNA damage |
GO:1905897 |
2.18% |
regulation of response to endoplasmic reticulum stress |
GO:0045936 |
2.17% |
negative regulation of phosphate metabolic process |
GO:0010662 |
2.17% |
regulation of striated muscle cell apoptotic process |
GO:0071902 |
2.17% |
positive regulation of protein serine/threonine kinase activity |
GO:0045745 |
2.17% |
positive regulation of G protein-coupled receptor signaling pathway |
GO:2001237 |
2.16% |
negative regulation of extrinsic apoptotic signaling pathway |
GO:0042832 |
2.16% |
defense response to protozoan |
GO:0010563 |
2.16% |
negative regulation of phosphorus metabolic process |
GO:0060135 |
2.15% |
maternal process involved in female pregnancy |
GO:0007259 |
2.15% |
receptor signaling pathway via JAK-STAT |
GO:1901135 |
2.15% |
carbohydrate derivative metabolic process |
GO:0043412 |
2.15% |
macromolecule modification |
GO:0006956 |
2.15% |
complement activation |
GO:0043043 |
2.14% |
peptide biosynthetic process |
GO:0034645 |
2.14% |
cellular macromolecule biosynthetic process |
GO:0032868 |
2.14% |
response to insulin |
GO:0045662 |
2.14% |
negative regulation of myoblast differentiation |
GO:0002263 |
2.13% |
cell activation involved in immune response |
GO:0008366 |
2.13% |
axon ensheathment |
GO:0060179 |
2.13% |
male mating behavior |
GO:0007349 |
2.13% |
cellularization |
GO:1901655 |
2.13% |
cellular response to ketone |
GO:0006066 |
2.13% |
alcohol metabolic process |
GO:1902115 |
2.13% |
regulation of organelle assembly |
GO:0042133 |
2.13% |
neurotransmitter metabolic process |
GO:0009648 |
2.13% |
photoperiodism |
GO:0097696 |
2.12% |
receptor signaling pathway via STAT |
GO:0018193 |
2.12% |
peptidyl-amino acid modification |
GO:0071375 |
2.12% |
cellular response to peptide hormone stimulus |
GO:0030324 |
2.12% |
lung development |
GO:0042048 |
2.12% |
olfactory behavior |
GO:0006396 |
2.11% |
RNA processing |
GO:0046907 |
2.11% |
intracellular transport |
GO:0046486 |
2.11% |
glycerolipid metabolic process |
GO:0007010 |
2.11% |
cytoskeleton organization |
GO:0032535 |
2.11% |
regulation of cellular component size |
GO:0006584 |
2.11% |
catecholamine metabolic process |
GO:0061900 |
2.11% |
glial cell activation |
GO:0009651 |
2.11% |
response to salt stress |
GO:0032732 |
2.11% |
positive regulation of interleukin-1 production |
GO:0046902 |
2.10% |
regulation of mitochondrial membrane permeability |
GO:0002685 |
2.10% |
regulation of leukocyte migration |
GO:0090183 |
2.10% |
regulation of kidney development |
GO:0030522 |
2.10% |
intracellular receptor signaling pathway |
GO:0045444 |
2.10% |
fat cell differentiation |
GO:1902107 |
2.10% |
positive regulation of leukocyte differentiation |
GO:0050869 |
2.10% |
negative regulation of B cell activation |
GO:0001890 |
2.10% |
placenta development |
GO:0043269 |
2.09% |
regulation of ion transport |
GO:1901992 |
2.09% |
positive regulation of mitotic cell cycle phase transition |
GO:0010661 |
2.09% |
positive regulation of muscle cell apoptotic process |
GO:0035239 |
2.09% |
tube morphogenesis |
GO:0045648 |
2.09% |
positive regulation of erythrocyte differentiation |
GO:0006412 |
2.08% |
translation |
GO:0009060 |
2.08% |
aerobic respiration |
GO:0016050 |
2.08% |
vesicle organization |
GO:0051447 |
2.07% |
negative regulation of meiotic cell cycle |
GO:0008037 |
2.07% |
cell recognition |
GO:0060759 |
2.07% |
regulation of response to cytokine stimulus |
GO:0044550 |
2.07% |
secondary metabolite biosynthetic process |
GO:0097529 |
2.07% |
myeloid leukocyte migration |
GO:0007179 |
2.07% |
transforming growth factor beta receptor signaling pathway |
GO:0035296 |
2.07% |
regulation of tube diameter |
GO:1905523 |
2.06% |
positive regulation of macrophage migration |
GO:0030510 |
2.06% |
regulation of BMP signaling pathway |
GO:0035108 |
2.06% |
limb morphogenesis |
GO:0070670 |
2.06% |
response to interleukin-4 |
GO:0007548 |
2.06% |
sex differentiation |
GO:0006801 |
2.06% |
superoxide metabolic process |
GO:0045835 |
2.06% |
negative regulation of meiotic nuclear division |
GO:0030595 |
2.06% |
leukocyte chemotaxis |
GO:0001708 |
2.05% |
cell fate specification |
GO:0048662 |
2.05% |
negative regulation of smooth muscle cell proliferation |
GO:0021954 |
2.05% |
central nervous system neuron development |
GO:1901988 |
2.05% |
negative regulation of cell cycle phase transition |
GO:0006790 |
2.05% |
sulfur compound metabolic process |
GO:0001937 |
2.05% |
negative regulation of endothelial cell proliferation |
GO:0009059 |
2.05% |
macromolecule biosynthetic process |
GO:0002790 |
2.04% |
peptide secretion |
GO:0035107 |
2.04% |
appendage morphogenesis |
GO:0017015 |
2.04% |
regulation of transforming growth factor beta receptor signaling pathway |
GO:0055081 |
2.04% |
anion homeostasis |
GO:0045576 |
2.04% |
mast cell activation |
GO:0015918 |
2.03% |
sterol transport |
GO:0008286 |
2.03% |
insulin receptor signaling pathway |
GO:0090184 |
2.02% |
positive regulation of kidney development |
GO:0030435 |
2.02% |
sporulation resulting in formation of a cellular spore |
GO:0008154 |
2.02% |
actin polymerization or depolymerization |
GO:0009886 |
2.02% |
post-embryonic animal morphogenesis |
GO:0007507 |
2.02% |
heart development |
GO:0007272 |
2.02% |
ensheathment of neurons |
GO:0042446 |
2.02% |
hormone biosynthetic process |
GO:0045638 |
2.02% |
negative regulation of myeloid cell differentiation |
GO:0097746 |
2.01% |
regulation of blood vessel diameter |
GO:0043154 |
2.01% |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0046885 |
2.01% |
regulation of hormone biosynthetic process |
GO:0032434 |
2.01% |
regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO:0110149 |
2.01% |
regulation of biomineralization |
GO:0010043 |
2.01% |
response to zinc ion |
GO:2001021 |
2.01% |
negative regulation of response to DNA damage stimulus |
GO:0071467 |
2.01% |
cellular response to pH |
GO:0030901 |
2.00% |
midbrain development |
GO:0046034 |
2.00% |
ATP metabolic process |
GO:1903050 |
2.00% |
regulation of proteolysis involved in cellular protein catabolic process |
GO:0030279 |
2.00% |
negative regulation of ossification |
GO:0006397 |
2.00% |
mRNA processing |
GO:0042326 |
2.00% |
negative regulation of phosphorylation |
GO:0051047 |
2.00% |
positive regulation of secretion |
GO:0048247 |
1.99% |
lymphocyte chemotaxis |
GO:0070167 |
1.99% |
regulation of biomineral tissue development |
GO:0030500 |
1.99% |
regulation of bone mineralization |
GO:0001755 |
1.99% |
neural crest cell migration |
GO:0010508 |
1.99% |
positive regulation of autophagy |
GO:0008380 |
1.99% |
RNA splicing |
GO:1903530 |
1.99% |
regulation of secretion by cell |
GO:0045580 |
1.99% |
regulation of T cell differentiation |
GO:0010837 |
1.99% |
regulation of keratinocyte proliferation |
GO:0007632 |
1.99% |
visual behavior |
GO:0048661 |
1.98% |
positive regulation of smooth muscle cell proliferation |
GO:0022602 |
1.98% |
ovulation cycle process |
GO:0042058 |
1.98% |
regulation of epidermal growth factor receptor signaling pathway |
GO:0030728 |
1.98% |
ovulation |
GO:1990928 |
1.97% |
response to amino acid starvation |
GO:0006631 |
1.97% |
fatty acid metabolic process |
GO:1903319 |
1.97% |
positive regulation of protein maturation |
GO:0006820 |
1.97% |
anion transport |
GO:0034976 |
1.97% |
response to endoplasmic reticulum stress |
GO:0002832 |
1.97% |
negative regulation of response to biotic stimulus |
GO:0034654 |
1.97% |
nucleobase-containing compound biosynthetic process |
GO:0033555 |
1.97% |
multicellular organismal response to stress |
GO:0006694 |
1.96% |
steroid biosynthetic process |
GO:0043903 |
1.96% |
regulation of symbiosis, encompassing mutualism through parasitism |
GO:0043604 |
1.96% |
amide biosynthetic process |
GO:0001776 |
1.96% |
leukocyte homeostasis |
GO:0006082 |
1.96% |
organic acid metabolic process |
GO:0050867 |
1.95% |
positive regulation of cell activation |
GO:1903313 |
1.94% |
positive regulation of mRNA metabolic process |
GO:0061062 |
1.94% |
regulation of nematode larval development |
GO:0009738 |
1.94% |
abscisic acid-activated signaling pathway |
GO:0009751 |
1.94% |
response to salicylic acid |
GO:1901184 |
1.94% |
regulation of ERBB signaling pathway |
GO:0002696 |
1.93% |
positive regulation of leukocyte activation |
GO:0045785 |
1.93% |
positive regulation of cell adhesion |
GO:0050922 |
1.93% |
negative regulation of chemotaxis |
GO:0031139 |
1.93% |
positive regulation of conjugation with cellular fusion |
GO:0050931 |
1.93% |
pigment cell differentiation |
GO:0007017 |
1.93% |
microtubule-based process |
GO:1901222 |
1.93% |
regulation of NIK/NF-kappaB signaling |
GO:0072073 |
1.93% |
kidney epithelium development |
GO:0035019 |
1.92% |
somatic stem cell population maintenance |
GO:0022408 |
1.92% |
negative regulation of cell-cell adhesion |
GO:0033044 |
1.92% |
regulation of chromosome organization |
GO:0072521 |
1.92% |
purine-containing compound metabolic process |
GO:0002833 |
1.92% |
positive regulation of response to biotic stimulus |
GO:0021782 |
1.92% |
glial cell development |
GO:0045604 |
1.92% |
regulation of epidermal cell differentiation |
GO:0001959 |
1.92% |
regulation of cytokine-mediated signaling pathway |
GO:0009644 |
1.92% |
response to high light intensity |
GO:0006261 |
1.91% |
DNA-dependent DNA replication |
GO:0045787 |
1.91% |
positive regulation of cell cycle |
GO:0055086 |
1.91% |
nucleobase-containing small molecule metabolic process |
GO:0032787 |
1.91% |
monocarboxylic acid metabolic process |
GO:1902041 |
1.91% |
regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0032368 |
1.91% |
regulation of lipid transport |
GO:0120163 |
1.91% |
negative regulation of cold-induced thermogenesis |
GO:0010954 |
1.91% |
positive regulation of protein processing |
GO:0043436 |
1.91% |
oxoacid metabolic process |
GO:0071466 |
1.90% |
cellular response to xenobiotic stimulus |
GO:0006812 |
1.90% |
cation transport |
GO:0042632 |
1.90% |
cholesterol homeostasis |
GO:0071549 |
1.90% |
cellular response to dexamethasone stimulus |
GO:0010660 |
1.90% |
regulation of muscle cell apoptotic process |
GO:0002052 |
1.90% |
positive regulation of neuroblast proliferation |
GO:0051048 |
1.89% |
negative regulation of secretion |
GO:0045932 |
1.89% |
negative regulation of muscle contraction |
GO:0045185 |
1.89% |
maintenance of protein location |
GO:0045667 |
1.89% |
regulation of osteoblast differentiation |
GO:0043331 |
1.89% |
response to dsRNA |
GO:0043299 |
1.89% |
leukocyte degranulation |
GO:0008361 |
1.89% |
regulation of cell size |
GO:0002703 |
1.89% |
regulation of leukocyte mediated immunity |
GO:1900424 |
1.89% |
regulation of defense response to bacterium |
GO:0007530 |
1.88% |
sex determination |
GO:0009635 |
1.88% |
response to herbicide |
GO:0009723 |
1.88% |
response to ethylene |
GO:0090092 |
1.87% |
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0060560 |
1.87% |
developmental growth involved in morphogenesis |
GO:0032369 |
1.87% |
negative regulation of lipid transport |
GO:0051235 |
1.87% |
maintenance of location |
GO:0008542 |
1.87% |
visual learning |
GO:1904035 |
1.87% |
regulation of epithelial cell apoptotic process |
GO:2001243 |
1.87% |
negative regulation of intrinsic apoptotic signaling pathway |
GO:0050817 |
1.86% |
coagulation |
GO:0043457 |
1.86% |
regulation of cellular respiration |
GO:0070269 |
1.86% |
pyroptosis |
GO:0047484 |
1.86% |
regulation of response to osmotic stress |
GO:0042044 |
1.86% |
fluid transport |
GO:0035162 |
1.86% |
embryonic hemopoiesis |
GO:0016999 |
1.86% |
antibiotic metabolic process |
GO:0002366 |
1.86% |
leukocyte activation involved in immune response |
GO:0018105 |
1.86% |
peptidyl-serine phosphorylation |
GO:0030072 |
1.86% |
peptide hormone secretion |
GO:0018212 |
1.86% |
peptidyl-tyrosine modification |
GO:0034754 |
1.85% |
cellular hormone metabolic process |
GO:0009793 |
1.85% |
embryo development ending in seed dormancy |
GO:0052803 |
1.85% |
imidazole-containing compound metabolic process |
GO:0019637 |
1.85% |
organophosphate metabolic process |
GO:0045685 |
1.85% |
regulation of glial cell differentiation |
GO:0006805 |
1.85% |
xenobiotic metabolic process |
GO:0019752 |
1.85% |
carboxylic acid metabolic process |
GO:0055082 |
1.84% |
cellular chemical homeostasis |
GO:0098754 |
1.84% |
detoxification |
GO:0045981 |
1.84% |
positive regulation of nucleotide metabolic process |
GO:0000122 |
1.84% |
negative regulation of transcription by RNA polymerase II |
GO:1903844 |
1.84% |
regulation of cellular response to transforming growth factor beta stimulus |
GO:1990089 |
1.84% |
response to nerve growth factor |
GO:1990090 |
1.83% |
cellular response to nerve growth factor stimulus |
GO:0071560 |
1.83% |
cellular response to transforming growth factor beta stimulus |
GO:1903428 |
1.83% |
positive regulation of reactive oxygen species biosynthetic process |
GO:0045017 |
1.83% |
glycerolipid biosynthetic process |
GO:0031136 |
1.83% |
positive regulation of conjugation |
GO:0050808 |
1.83% |
synapse organization |
GO:0045616 |
1.83% |
regulation of keratinocyte differentiation |
GO:0043934 |
1.83% |
sporulation |
GO:1903046 |
1.83% |
meiotic cell cycle process |
GO:0051952 |
1.83% |
regulation of amine transport |
GO:0048240 |
1.82% |
sperm capacitation |
GO:0042476 |
1.82% |
odontogenesis |
GO:0003014 |
1.82% |
renal system process |
GO:0009798 |
1.81% |
axis specification |
GO:0002687 |
1.81% |
positive regulation of leukocyte migration |
GO:2000351 |
1.81% |
regulation of endothelial cell apoptotic process |
GO:0055065 |
1.81% |
metal ion homeostasis |
GO:0015748 |
1.80% |
organophosphate ester transport |
GO:0018108 |
1.80% |
peptidyl-tyrosine phosphorylation |
GO:0050909 |
1.80% |
sensory perception of taste |
GO:1902742 |
1.80% |
apoptotic process involved in development |
GO:1902230 |
1.80% |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
GO:1902074 |
1.80% |
response to salt |
GO:1905809 |
1.80% |
negative regulation of synapse organization |
GO:0002690 |
1.79% |
positive regulation of leukocyte chemotaxis |
GO:1901989 |
1.79% |
positive regulation of cell cycle phase transition |
GO:0051445 |
1.79% |
regulation of meiotic cell cycle |
GO:0007635 |
1.79% |
chemosensory behavior |
GO:0050996 |
1.79% |
positive regulation of lipid catabolic process |
GO:0032880 |
1.78% |
regulation of protein localization |
GO:2001022 |
1.78% |
positive regulation of response to DNA damage stimulus |
GO:0002886 |
1.78% |
regulation of myeloid leukocyte mediated immunity |
GO:1990748 |
1.78% |
cellular detoxification |
GO:0002119 |
1.78% |
nematode larval development |
GO:1903727 |
1.78% |
positive regulation of phospholipid metabolic process |
GO:0007162 |
1.78% |
negative regulation of cell adhesion |
GO:0007064 |
1.78% |
mitotic sister chromatid cohesion |
GO:0044058 |
1.77% |
regulation of digestive system process |
GO:0010470 |
1.77% |
regulation of gastrulation |
GO:0072347 |
1.77% |
response to anesthetic |
GO:0009268 |
1.77% |
response to pH |
GO:0002260 |
1.77% |
lymphocyte homeostasis |
GO:0032386 |
1.77% |
regulation of intracellular transport |
GO:0051099 |
1.77% |
positive regulation of binding |
GO:0034405 |
1.77% |
response to fluid shear stress |
GO:0071248 |
1.77% |
cellular response to metal ion |
GO:0002688 |
1.77% |
regulation of leukocyte chemotaxis |
GO:0043029 |
1.77% |
T cell homeostasis |
GO:1904037 |
1.77% |
positive regulation of epithelial cell apoptotic process |
GO:0006110 |
1.76% |
regulation of glycolytic process |
GO:0032649 |
1.76% |
regulation of interferon-gamma production |
GO:0035094 |
1.76% |
response to nicotine |
GO:0071887 |
1.76% |
leukocyte apoptotic process |
GO:0090087 |
1.76% |
regulation of peptide transport |
GO:0051954 |
1.76% |
positive regulation of amine transport |
GO:0048048 |
1.76% |
embryonic eye morphogenesis |
GO:0006937 |
1.75% |
regulation of muscle contraction |
GO:0070664 |
1.75% |
negative regulation of leukocyte proliferation |
GO:1900544 |
1.75% |
positive regulation of purine nucleotide metabolic process |
GO:0022407 |
1.75% |
regulation of cell-cell adhesion |
GO:0006633 |
1.75% |
fatty acid biosynthetic process |
GO:0060326 |
1.75% |
cell chemotaxis |
GO:0003015 |
1.74% |
heart process |
GO:0045721 |
1.74% |
negative regulation of gluconeogenesis |
GO:2000179 |
1.74% |
positive regulation of neural precursor cell proliferation |
GO:0006353 |
1.74% |
DNA-templated transcription, termination |
GO:0061136 |
1.74% |
regulation of proteasomal protein catabolic process |
GO:0051249 |
1.74% |
regulation of lymphocyte activation |
GO:1900371 |
1.74% |
regulation of purine nucleotide biosynthetic process |
GO:0051150 |
1.74% |
regulation of smooth muscle cell differentiation |
GO:0001658 |
1.74% |
branching involved in ureteric bud morphogenesis |
GO:0050921 |
1.74% |
positive regulation of chemotaxis |
GO:0055092 |
1.74% |
sterol homeostasis |
GO:0098771 |
1.74% |
inorganic ion homeostasis |
GO:0034050 |
1.73% |
host programmed cell death induced by symbiont |
GO:1902807 |
1.73% |
negative regulation of cell cycle G1/S phase transition |
GO:0048525 |
1.73% |
negative regulation of viral process |
GO:0043550 |
1.73% |
regulation of lipid kinase activity |
GO:0097530 |
1.73% |
granulocyte migration |
GO:0046883 |
1.73% |
regulation of hormone secretion |
GO:0030041 |
1.73% |
actin filament polymerization |
GO:0090069 |
1.72% |
regulation of ribosome biogenesis |
GO:0050863 |
1.72% |
regulation of T cell activation |
GO:0016042 |
1.72% |
lipid catabolic process |
GO:0060260 |
1.72% |
regulation of transcription initiation from RNA polymerase II promoter |
GO:0051961 |
1.72% |
negative regulation of nervous system development |
GO:0034613 |
1.72% |
cellular protein localization |
GO:0072330 |
1.72% |
monocarboxylic acid biosynthetic process |
GO:0009117 |
1.72% |
nucleotide metabolic process |
GO:0051603 |
1.72% |
proteolysis involved in cellular protein catabolic process |
GO:0008156 |
1.72% |
negative regulation of DNA replication |
GO:0007205 |
1.72% |
protein kinase C-activating G protein-coupled receptor signaling pathway |
GO:0001539 |
1.72% |
cilium or flagellum-dependent cell motility |
GO:0060341 |
1.71% |
regulation of cellular localization |
GO:0002164 |
1.71% |
larval development |
GO:0045732 |
1.71% |
positive regulation of protein catabolic process |
GO:0035113 |
1.71% |
embryonic appendage morphogenesis |
GO:0006753 |
1.71% |
nucleoside phosphate metabolic process |
GO:0051703 |
1.70% |
intraspecies interaction between organisms |
GO:0032689 |
1.70% |
negative regulation of interferon-gamma production |
GO:0019646 |
1.70% |
aerobic electron transport chain |
GO:0007409 |
1.70% |
axonogenesis |
GO:0007292 |
1.70% |
female gamete generation |
GO:0046999 |
1.70% |
regulation of conjugation |
GO:1901796 |
1.70% |
regulation of signal transduction by p53 class mediator |
GO:0008104 |
1.70% |
protein localization |
GO:0090279 |
1.70% |
regulation of calcium ion import |
GO:0010631 |
1.70% |
epithelial cell migration |
GO:0006281 |
1.69% |
DNA repair |
GO:0033036 |
1.69% |
macromolecule localization |
GO:0006310 |
1.69% |
DNA recombination |
GO:1901216 |
1.69% |
positive regulation of neuron death |
GO:0031137 |
1.69% |
regulation of conjugation with cellular fusion |
GO:0070663 |
1.69% |
regulation of leukocyte proliferation |
GO:0050772 |
1.69% |
positive regulation of axonogenesis |
GO:0030705 |
1.69% |
cytoskeleton-dependent intracellular transport |
GO:0060415 |
1.69% |
muscle tissue morphogenesis |
GO:0030217 |
1.69% |
T cell differentiation |
GO:0003156 |
1.69% |
regulation of animal organ formation |
GO:0015711 |
1.69% |
organic anion transport |
GO:0042886 |
1.69% |
amide transport |
GO:0050821 |
1.69% |
protein stabilization |
GO:0070169 |
1.68% |
positive regulation of biomineral tissue development |
GO:0043525 |
1.68% |
positive regulation of neuron apoptotic process |
GO:0032370 |
1.68% |
positive regulation of lipid transport |
GO:0002253 |
1.68% |
activation of immune response |
GO:0033013 |
1.68% |
tetrapyrrole metabolic process |
GO:0071300 |
1.67% |
cellular response to retinoic acid |
GO:0007596 |
1.67% |
blood coagulation |
GO:0014013 |
1.67% |
regulation of gliogenesis |
GO:0070727 |
1.67% |
cellular macromolecule localization |
GO:1903798 |
1.67% |
regulation of production of miRNAs involved in gene silencing by miRNA |
GO:0055080 |
1.67% |
cation homeostasis |
GO:0051153 |
1.67% |
regulation of striated muscle cell differentiation |
GO:0019236 |
1.67% |
response to pheromone |
GO:0001501 |
1.66% |
skeletal system development |
GO:0070570 |
1.66% |
regulation of neuron projection regeneration |
GO:0008582 |
1.66% |
regulation of synaptic growth at neuromuscular junction |
GO:0015833 |
1.66% |
peptide transport |
GO:0010799 |
1.66% |
regulation of peptidyl-threonine phosphorylation |
GO:0032922 |
1.66% |
circadian regulation of gene expression |
GO:0009734 |
1.66% |
auxin-activated signaling pathway |
GO:0090693 |
1.66% |
plant organ senescence |
GO:2000144 |
1.66% |
positive regulation of DNA-templated transcription, initiation |
GO:0032660 |
1.65% |
regulation of interleukin-17 production |
GO:1901890 |
1.65% |
positive regulation of cell junction assembly |
GO:0010498 |
1.65% |
proteasomal protein catabolic process |
GO:0007178 |
1.65% |
transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0051149 |
1.65% |
positive regulation of muscle cell differentiation |
GO:0043551 |
1.65% |
regulation of phosphatidylinositol 3-kinase activity |
GO:0046621 |
1.65% |
negative regulation of organ growth |
GO:0002312 |
1.64% |
B cell activation involved in immune response |
GO:1903047 |
1.64% |
mitotic cell cycle process |
GO:0120039 |
1.64% |
plasma membrane bounded cell projection morphogenesis |
GO:0032543 |
1.64% |
mitochondrial translation |
GO:1903670 |
1.64% |
regulation of sprouting angiogenesis |
GO:2000279 |
1.63% |
negative regulation of DNA biosynthetic process |
GO:1905820 |
1.63% |
positive regulation of chromosome separation |
GO:0009259 |
1.63% |
ribonucleotide metabolic process |
GO:0032092 |
1.63% |
positive regulation of protein binding |
GO:0030111 |
1.63% |
regulation of Wnt signaling pathway |
GO:0007249 |
1.63% |
I-kappaB kinase/NF-kappaB signaling |
GO:0009787 |
1.62% |
regulation of abscisic acid-activated signaling pathway |
GO:0002275 |
1.62% |
myeloid cell activation involved in immune response |
GO:0043502 |
1.62% |
regulation of muscle adaptation |
GO:0002675 |
1.62% |
positive regulation of acute inflammatory response |
GO:0055072 |
1.62% |
iron ion homeostasis |
GO:0033120 |
1.62% |
positive regulation of RNA splicing |
GO:1903531 |
1.61% |
negative regulation of secretion by cell |
GO:0110151 |
1.61% |
positive regulation of biomineralization |
GO:0046697 |
1.61% |
decidualization |
GO:0048812 |
1.61% |
neuron projection morphogenesis |
GO:0050433 |
1.61% |
regulation of catecholamine secretion |
GO:0001960 |
1.61% |
negative regulation of cytokine-mediated signaling pathway |
GO:0071675 |
1.61% |
regulation of mononuclear cell migration |
GO:0003085 |
1.61% |
negative regulation of systemic arterial blood pressure |
GO:0033238 |
1.61% |
regulation of cellular amine metabolic process |
GO:0002269 |
1.61% |
leukocyte activation involved in inflammatory response |
GO:0006638 |
1.61% |
neutral lipid metabolic process |
GO:0060760 |
1.60% |
positive regulation of response to cytokine stimulus |
GO:0140013 |
1.60% |
meiotic nuclear division |
GO:1905710 |
1.60% |
positive regulation of membrane permeability |
GO:0045669 |
1.59% |
positive regulation of osteoblast differentiation |
GO:0045599 |
1.59% |
negative regulation of fat cell differentiation |
GO:0010150 |
1.59% |
leaf senescence |
GO:0007599 |
1.59% |
hemostasis |
GO:0030029 |
1.59% |
actin filament-based process |
GO:1905957 |
1.59% |
regulation of cellular response to alcohol |
GO:0043588 |
1.59% |
skin development |
GO:0060148 |
1.59% |
positive regulation of posttranscriptional gene silencing |
GO:0043542 |
1.59% |
endothelial cell migration |
GO:0042069 |
1.59% |
regulation of catecholamine metabolic process |
GO:0042771 |
1.59% |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO:0051321 |
1.58% |
meiotic cell cycle |
GO:0032350 |
1.58% |
regulation of hormone metabolic process |
GO:0006163 |
1.58% |
purine nucleotide metabolic process |
GO:0002931 |
1.58% |
response to ischemia |
GO:2000178 |
1.57% |
negative regulation of neural precursor cell proliferation |
GO:0050768 |
1.57% |
negative regulation of neurogenesis |
GO:0046470 |
1.57% |
phosphatidylcholine metabolic process |
GO:0051602 |
1.57% |
response to electrical stimulus |
GO:0009415 |
1.57% |
response to water |
GO:1903364 |
1.57% |
positive regulation of cellular protein catabolic process |
GO:1900078 |
1.57% |
positive regulation of cellular response to insulin stimulus |
GO:0048858 |
1.57% |
cell projection morphogenesis |
GO:0002360 |
1.56% |
T cell lineage commitment |
GO:0098869 |
1.56% |
cellular oxidant detoxification |
GO:0046330 |
1.56% |
positive regulation of JNK cascade |
GO:2000134 |
1.56% |
negative regulation of G1/S transition of mitotic cell cycle |
GO:0009309 |
1.56% |
amine biosynthetic process |
GO:1902253 |
1.56% |
regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
GO:1905879 |
1.56% |
regulation of oogenesis |
GO:0070417 |
1.56% |
cellular response to cold |
GO:0022617 |
1.56% |
extracellular matrix disassembly |
GO:1904019 |
1.56% |
epithelial cell apoptotic process |
GO:0014031 |
1.56% |
mesenchymal cell development |
GO:0045778 |
1.56% |
positive regulation of ossification |
GO:0070201 |
1.56% |
regulation of establishment of protein localization |
GO:0044283 |
1.56% |
small molecule biosynthetic process |
GO:0048831 |
1.56% |
regulation of shoot system development |
GO:0043278 |
1.55% |
response to morphine |
GO:2000107 |
1.55% |
negative regulation of leukocyte apoptotic process |
GO:0060070 |
1.55% |
canonical Wnt signaling pathway |
GO:1904705 |
1.55% |
regulation of vascular smooth muscle cell proliferation |
GO:0009737 |
1.55% |
response to abscisic acid |
GO:0019724 |
1.55% |
B cell mediated immunity |
GO:0006308 |
1.55% |
DNA catabolic process |
GO:0072676 |
1.55% |
lymphocyte migration |
GO:1901566 |
1.55% |
organonitrogen compound biosynthetic process |
GO:0001952 |
1.55% |
regulation of cell-matrix adhesion |
GO:0002762 |
1.55% |
negative regulation of myeloid leukocyte differentiation |
GO:0030437 |
1.55% |
ascospore formation |
GO:0022413 |
1.54% |
reproductive process in single-celled organism |
GO:0043935 |
1.54% |
sexual sporulation resulting in formation of a cellular spore |
GO:0014910 |
1.54% |
regulation of smooth muscle cell migration |
GO:0015893 |
1.54% |
drug transport |
GO:0098801 |
1.54% |
regulation of renal system process |
GO:0002082 |
1.54% |
regulation of oxidative phosphorylation |
GO:0030514 |
1.54% |
negative regulation of BMP signaling pathway |
GO:0032735 |
1.54% |
positive regulation of interleukin-12 production |
GO:0042475 |
1.54% |
odontogenesis of dentin-containing tooth |
GO:0030326 |
1.53% |
embryonic limb morphogenesis |
GO:0006949 |
1.53% |
syncytium formation |
GO:0007614 |
1.53% |
short-term memory |
GO:0031638 |
1.53% |
zymogen activation |
GO:0010827 |
1.53% |
regulation of glucose transmembrane transport |
GO:0051898 |
1.53% |
negative regulation of protein kinase B signaling |
GO:0043114 |
1.53% |
regulation of vascular permeability |
GO:0009150 |
1.53% |
purine ribonucleotide metabolic process |
GO:0045736 |
1.53% |
negative regulation of cyclin-dependent protein serine/threonine kinase activity |
GO:0016075 |
1.53% |
rRNA catabolic process |
GO:0006144 |
1.53% |
purine nucleobase metabolic process |
GO:0042401 |
1.53% |
cellular biogenic amine biosynthetic process |
GO:0043161 |
1.52% |
proteasome-mediated ubiquitin-dependent protein catabolic process |
GO:0042130 |
1.52% |
negative regulation of T cell proliferation |
GO:0003382 |
1.52% |
epithelial cell morphogenesis |
GO:0010769 |
1.52% |
regulation of cell morphogenesis involved in differentiation |
GO:0030808 |
1.52% |
regulation of nucleotide biosynthetic process |
GO:0042246 |
1.52% |
tissue regeneration |
GO:0014015 |
1.52% |
positive regulation of gliogenesis |
GO:0050672 |
1.52% |
negative regulation of lymphocyte proliferation |
GO:0001774 |
1.51% |
microglial cell activation |
GO:0060251 |
1.51% |
regulation of glial cell proliferation |
GO:2000024 |
1.51% |
regulation of leaf development |
GO:0001933 |
1.51% |
negative regulation of protein phosphorylation |
GO:0007018 |
1.51% |
microtubule-based movement |
GO:0032655 |
1.51% |
regulation of interleukin-12 production |
GO:0030048 |
1.51% |
actin filament-based movement |
GO:0090090 |
1.51% |
negative regulation of canonical Wnt signaling pathway |
GO:0043087 |
1.51% |
regulation of GTPase activity |
GO:0043536 |
1.51% |
positive regulation of blood vessel endothelial cell migration |
GO:0009867 |
1.51% |
jasmonic acid mediated signaling pathway |
GO:0043489 |
1.51% |
RNA stabilization |
GO:0090322 |
1.51% |
regulation of superoxide metabolic process |
GO:0071402 |
1.51% |
cellular response to lipoprotein particle stimulus |
GO:0006260 |
1.50% |
DNA replication |
GO:0050892 |
1.50% |
intestinal absorption |
GO:0042026 |
1.50% |
protein refolding |
GO:1901419 |
1.50% |
regulation of response to alcohol |
GO:0050918 |
1.50% |
positive chemotaxis |
GO:0002791 |
1.50% |
regulation of peptide secretion |
GO:0040034 |
1.50% |
regulation of development, heterochronic |
GO:0030163 |
1.50% |
protein catabolic process |
GO:0061919 |
1.50% |
process utilizing autophagic mechanism |
GO:0007264 |
1.50% |
small GTPase mediated signal transduction |
GO:0006399 |
1.50% |
tRNA metabolic process |
GO:0043406 |
1.50% |
positive regulation of MAP kinase activity |
GO:1904396 |
1.50% |
regulation of neuromuscular junction development |
GO:0048705 |
1.50% |
skeletal system morphogenesis |
GO:0016036 |
1.50% |
cellular response to phosphate starvation |
GO:0032872 |
1.50% |
regulation of stress-activated MAPK cascade |
GO:0016032 |
1.49% |
viral process |
GO:0007193 |
1.49% |
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO:0090025 |
1.49% |
regulation of monocyte chemotaxis |
GO:0002698 |
1.49% |
negative regulation of immune effector process |
GO:0045824 |
1.49% |
negative regulation of innate immune response |
GO:0002712 |
1.49% |
regulation of B cell mediated immunity |
GO:0033003 |
1.48% |
regulation of mast cell activation |
GO:0019934 |
1.48% |
cGMP-mediated signaling |
GO:0010171 |
1.48% |
body morphogenesis |
GO:0046320 |
1.48% |
regulation of fatty acid oxidation |
GO:0007616 |
1.48% |
long-term memory |
GO:0071731 |
1.48% |
response to nitric oxide |
GO:0048679 |
1.48% |
response to isoquinoline alkaloid |
GO:0014072 |
1.48% |
regulation of axon regeneration |
GO:0042737 |
1.48% |
drug catabolic process |
GO:0044062 |
1.48% |
regulation of excretion |
GO:0016072 |
1.48% |
rRNA metabolic process |
GO:0045428 |
1.48% |
regulation of nitric oxide biosynthetic process |
GO:0051984 |
1.48% |
positive regulation of chromosome segregation |
GO:0002686 |
1.48% |
negative regulation of leukocyte migration |
GO:1902229 |
1.48% |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0009626 |
1.48% |
plant-type hypersensitive response |
GO:0001773 |
1.47% |
myeloid dendritic cell activation |
GO:0042692 |
1.47% |
muscle cell differentiation |
GO:0006639 |
1.47% |
acylglycerol metabolic process |
GO:0055010 |
1.47% |
ventricular cardiac muscle tissue morphogenesis |
GO:0031016 |
1.47% |
pancreas development |
GO:0097066 |
1.47% |
response to thyroid hormone |
GO:0006123 |
1.47% |
mitochondrial electron transport, cytochrome c to oxygen |
GO:0048536 |
1.47% |
spleen development |
GO:0003007 |
1.47% |
heart morphogenesis |
GO:0017157 |
1.46% |
regulation of exocytosis |
GO:0007140 |
1.46% |
male meiotic nuclear division |
GO:0060142 |
1.46% |
regulation of syncytium formation by plasma membrane fusion |
GO:0046626 |
1.46% |
regulation of insulin receptor signaling pathway |
GO:2001025 |
1.46% |
positive regulation of response to drug |
GO:0032945 |
1.46% |
negative regulation of mononuclear cell proliferation |
GO:0046068 |
1.46% |
cGMP metabolic process |
GO:0051101 |
1.46% |
regulation of DNA binding |
GO:0070373 |
1.46% |
negative regulation of ERK1 and ERK2 cascade |
GO:0048839 |
1.46% |
inner ear development |
GO:0060390 |
1.46% |
regulation of SMAD protein signal transduction |
GO:1900182 |
1.46% |
positive regulation of protein localization to nucleus |
GO:1905953 |
1.46% |
negative regulation of lipid localization |
GO:1901136 |
1.46% |
carbohydrate derivative catabolic process |
GO:0010042 |
1.46% |
response to manganese ion |
GO:0006972 |
1.46% |
hyperosmotic response |
GO:0043516 |
1.46% |
regulation of DNA damage response, signal transduction by p53 class mediator |
GO:0032007 |
1.46% |
negative regulation of TOR signaling |
GO:0010831 |
1.45% |
positive regulation of myotube differentiation |
GO:0070302 |
1.45% |
regulation of stress-activated protein kinase signaling cascade |
GO:0042116 |
1.45% |
macrophage activation |
GO:0071353 |
1.45% |
cellular response to interleukin-4 |
GO:0001764 |
1.45% |
neuron migration |
GO:1903573 |
1.45% |
negative regulation of response to endoplasmic reticulum stress |
GO:0006662 |
1.44% |
glycerol ether metabolic process |
GO:0051148 |
1.44% |
negative regulation of muscle cell differentiation |
GO:1901570 |
1.44% |
fatty acid derivative biosynthetic process |
GO:0050886 |
1.44% |
endocrine process |
GO:0043279 |
1.44% |
response to alkaloid |
GO:0071276 |
1.44% |
cellular response to cadmium ion |
GO:0019693 |
1.44% |
ribose phosphate metabolic process |
GO:0035136 |
1.44% |
forelimb morphogenesis |
GO:0060761 |
1.44% |
negative regulation of response to cytokine stimulus |
GO:0032784 |
1.44% |
regulation of DNA-templated transcription, elongation |
GO:0035188 |
1.44% |
hatching |
GO:0048544 |
1.43% |
recognition of pollen |
GO:0055008 |
1.43% |
cardiac muscle tissue morphogenesis |
GO:0000278 |
1.43% |
mitotic cell cycle |
GO:0080154 |
1.43% |
regulation of fertilization |
GO:0090101 |
1.43% |
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0045687 |
1.43% |
positive regulation of glial cell differentiation |
GO:0045793 |
1.43% |
positive regulation of cell size |
GO:0009414 |
1.43% |
response to water deprivation |
GO:0048259 |
1.42% |
regulation of receptor-mediated endocytosis |
GO:0045088 |
1.42% |
regulation of innate immune response |
GO:1903052 |
1.42% |
positive regulation of proteolysis involved in cellular protein catabolic process |
GO:0051188 |
1.42% |
cofactor biosynthetic process |
GO:0022618 |
1.42% |
ribonucleoprotein complex assembly |
GO:0070085 |
1.42% |
glycosylation |
GO:0045620 |
1.42% |
negative regulation of lymphocyte differentiation |
GO:0030178 |
1.42% |
negative regulation of Wnt signaling pathway |
GO:1901797 |
1.42% |
negative regulation of signal transduction by p53 class mediator |
GO:0030890 |
1.42% |
positive regulation of B cell proliferation |
GO:0043409 |
1.42% |
negative regulation of MAPK cascade |
GO:0009753 |
1.42% |
response to jasmonic acid |
GO:0051187 |
1.42% |
cofactor catabolic process |
GO:0046622 |
1.42% |
positive regulation of organ growth |
GO:2001222 |
1.41% |
regulation of neuron migration |
GO:0051250 |
1.41% |
negative regulation of lymphocyte activation |
GO:1904706 |
1.41% |
negative regulation of vascular smooth muscle cell proliferation |
GO:0051223 |
1.41% |
regulation of protein transport |
GO:0031647 |
1.41% |
regulation of protein stability |
GO:0043500 |
1.41% |
muscle adaptation |
GO:0031400 |
1.41% |
negative regulation of protein modification process |
GO:0060359 |
1.41% |
response to ammonium ion |
GO:0006379 |
1.41% |
mRNA cleavage |
GO:0009642 |
1.41% |
response to light intensity |
GO:0070665 |
1.41% |
positive regulation of leukocyte proliferation |
GO:0050685 |
1.41% |
positive regulation of mRNA processing |
GO:1903312 |
1.41% |
negative regulation of mRNA metabolic process |
GO:0006914 |
1.40% |
autophagy |
GO:0007229 |
1.40% |
integrin-mediated signaling pathway |
GO:0042303 |
1.40% |
molting cycle |
GO:0006650 |
1.40% |
glycerophospholipid metabolic process |
GO:0010676 |
1.40% |
positive regulation of cellular carbohydrate metabolic process |
GO:0046328 |
1.40% |
regulation of JNK cascade |
GO:0014850 |
1.40% |
response to muscle activity |
GO:0001961 |
1.40% |
positive regulation of cytokine-mediated signaling pathway |
GO:1903320 |
1.40% |
regulation of protein modification by small protein conjugation or removal |
GO:0048864 |
1.40% |
stem cell development |
GO:0006111 |
1.40% |
regulation of gluconeogenesis |
GO:0042572 |
1.40% |
retinol metabolic process |
GO:0032786 |
1.39% |
positive regulation of DNA-templated transcription, elongation |
GO:0099177 |
1.39% |
regulation of trans-synaptic signaling |
GO:0045184 |
1.39% |
establishment of protein localization |
GO:0043562 |
1.39% |
cellular response to nitrogen levels |
GO:0034394 |
1.39% |
protein localization to cell surface |
GO:0043255 |
1.39% |
regulation of carbohydrate biosynthetic process |
GO:0005975 |
1.39% |
carbohydrate metabolic process |
GO:2000249 |
1.39% |
regulation of actin cytoskeleton reorganization |
GO:0031341 |
1.39% |
regulation of cell killing |
GO:0010959 |
1.39% |
regulation of metal ion transport |
GO:0010883 |
1.39% |
regulation of lipid storage |
GO:1903409 |
1.38% |
reactive oxygen species biosynthetic process |
GO:0072163 |
1.38% |
mesonephric epithelium development |
GO:0045939 |
1.38% |
negative regulation of steroid metabolic process |
GO:0006511 |
1.38% |
ubiquitin-dependent protein catabolic process |
GO:0034391 |
1.38% |
regulation of smooth muscle cell apoptotic process |
GO:0007187 |
1.38% |
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0032069 |
1.38% |
regulation of nuclease activity |
GO:0007619 |
1.38% |
courtship behavior |
GO:0015031 |
1.38% |
protein transport |
GO:1902893 |
1.38% |
regulation of pri-miRNA transcription by RNA polymerase II |
GO:1901991 |
1.38% |
negative regulation of mitotic cell cycle phase transition |
GO:0051276 |
1.38% |
chromosome organization |
GO:0009988 |
1.37% |
cell-cell recognition |
GO:0050684 |
1.37% |
regulation of mRNA processing |
GO:1990266 |
1.37% |
neutrophil migration |
GO:0006268 |
1.37% |
DNA unwinding involved in DNA replication |
GO:0043473 |
1.37% |
pigmentation |
GO:0032968 |
1.37% |
positive regulation of transcription elongation from RNA polymerase II promoter |
GO:1900087 |
1.37% |
positive regulation of G1/S transition of mitotic cell cycle |
GO:1905818 |
1.37% |
regulation of chromosome separation |
GO:0030001 |
1.37% |
metal ion transport |
GO:0022008 |
1.37% |
neurogenesis |
GO:0006282 |
1.37% |
regulation of DNA repair |
GO:0040020 |
1.37% |
regulation of meiotic nuclear division |
GO:0048255 |
1.36% |
mRNA stabilization |
GO:0090342 |
1.36% |
regulation of cell aging |
GO:0051783 |
1.36% |
regulation of nuclear division |
GO:0044070 |
1.36% |
regulation of anion transport |
GO:0030168 |
1.36% |
platelet activation |
GO:0061982 |
1.36% |
meiosis I cell cycle process |
GO:0014911 |
1.36% |
positive regulation of smooth muscle cell migration |
GO:0051654 |
1.36% |
establishment of mitochondrion localization |
GO:0016053 |
1.36% |
organic acid biosynthetic process |
GO:0006458 |
1.36% |
'de novo' protein folding |
GO:1902373 |
1.36% |
negative regulation of mRNA catabolic process |
GO:0010623 |
1.35% |
programmed cell death involved in cell development |
GO:0048477 |
1.35% |
oogenesis |
GO:0045723 |
1.35% |
positive regulation of fatty acid biosynthetic process |
GO:2000637 |
1.35% |
positive regulation of gene silencing by miRNA |
GO:0010823 |
1.35% |
negative regulation of mitochondrion organization |
GO:0002889 |
1.35% |
regulation of immunoglobulin mediated immune response |
GO:0032365 |
1.35% |
intracellular lipid transport |
GO:0009952 |
1.35% |
anterior/posterior pattern specification |
GO:0010970 |
1.35% |
transport along microtubule |
GO:0098630 |
1.34% |
aggregation of unicellular organisms |
GO:0071103 |
1.34% |
DNA conformation change |
GO:1901678 |
1.34% |
iron coordination entity transport |
GO:0048261 |
1.34% |
negative regulation of receptor-mediated endocytosis |
GO:0048581 |
1.34% |
negative regulation of post-embryonic development |
GO:1904030 |
1.34% |
negative regulation of cyclin-dependent protein kinase activity |
GO:0009953 |
1.34% |
dorsal/ventral pattern formation |
GO:0002718 |
1.34% |
regulation of cytokine production involved in immune response |
GO:0031343 |
1.34% |
positive regulation of cell killing |
GO:0008585 |
1.34% |
female gonad development |
GO:0045668 |
1.34% |
negative regulation of osteoblast differentiation |
GO:0072678 |
1.33% |
T cell migration |
GO:0048147 |
1.33% |
negative regulation of fibroblast proliferation |
GO:0009880 |
1.33% |
embryonic pattern specification |
GO:0001656 |
1.33% |
metanephros development |
GO:0030513 |
1.33% |
positive regulation of BMP signaling pathway |
GO:0048704 |
1.33% |
embryonic skeletal system morphogenesis |
GO:0048709 |
1.33% |
oligodendrocyte differentiation |
GO:1903008 |
1.33% |
organelle disassembly |
GO:0090068 |
1.33% |
positive regulation of cell cycle process |
GO:0009639 |
1.33% |
response to red or far red light |
GO:0097366 |
1.33% |
response to bronchodilator |
GO:0050792 |
1.32% |
regulation of viral process |
GO:0031570 |
1.32% |
DNA integrity checkpoint |
GO:0051348 |
1.32% |
negative regulation of transferase activity |
GO:0002705 |
1.32% |
positive regulation of leukocyte mediated immunity |
GO:0072595 |
1.32% |
maintenance of protein localization in organelle |
GO:1903322 |
1.32% |
positive regulation of protein modification by small protein conjugation or removal |
GO:0042157 |
1.32% |
lipoprotein metabolic process |
GO:0140253 |
1.32% |
cell-cell fusion |
GO:0034110 |
1.32% |
regulation of homotypic cell-cell adhesion |
GO:0046474 |
1.32% |
glycerophospholipid biosynthetic process |
GO:0001662 |
1.32% |
behavioral fear response |
GO:0070228 |
1.32% |
regulation of lymphocyte apoptotic process |
GO:1903305 |
1.32% |
regulation of regulated secretory pathway |
GO:0002793 |
1.32% |
positive regulation of peptide secretion |
GO:0000375 |
1.32% |
RNA splicing, via transesterification reactions |
GO:0032869 |
1.32% |
cellular response to insulin stimulus |
GO:0030100 |
1.32% |
regulation of endocytosis |
GO:0006352 |
1.31% |
DNA-templated transcription, initiation |
GO:0001944 |
1.31% |
vasculature development |
GO:0090218 |
1.31% |
positive regulation of lipid kinase activity |
GO:0071869 |
1.31% |
response to catecholamine |
GO:0032148 |
1.31% |
activation of protein kinase B activity |
GO:1902808 |
1.31% |
positive regulation of cell cycle G1/S phase transition |
GO:0061014 |
1.31% |
positive regulation of mRNA catabolic process |
GO:0006940 |
1.31% |
regulation of smooth muscle contraction |
GO:0010894 |
1.30% |
negative regulation of steroid biosynthetic process |
GO:0050766 |
1.30% |
positive regulation of phagocytosis |
GO:0006995 |
1.30% |
cellular response to nitrogen starvation |
GO:0043552 |
1.30% |
positive regulation of phosphatidylinositol 3-kinase activity |
GO:0047497 |
1.30% |
mitochondrion transport along microtubule |
GO:0045830 |
1.30% |
positive regulation of isotype switching |
GO:0009733 |
1.30% |
response to auxin |
GO:0045746 |
1.30% |
negative regulation of Notch signaling pathway |
GO:0045191 |
1.30% |
regulation of isotype switching |
GO:0002888 |
1.30% |
positive regulation of myeloid leukocyte mediated immunity |
GO:0060828 |
1.29% |
regulation of canonical Wnt signaling pathway |
GO:0010803 |
1.29% |
regulation of tumor necrosis factor-mediated signaling pathway |
GO:0060706 |
1.29% |
cell differentiation involved in embryonic placenta development |
GO:1905939 |
1.29% |
regulation of gonad development |
GO:0046394 |
1.29% |
carboxylic acid biosynthetic process |
GO:1902991 |
1.29% |
regulation of amyloid precursor protein catabolic process |
GO:0006022 |
1.29% |
aminoglycan metabolic process |
GO:0071622 |
1.29% |
regulation of granulocyte chemotaxis |
GO:0000737 |
1.29% |
DNA catabolic process, endonucleolytic |
GO:0045686 |
1.29% |
negative regulation of glial cell differentiation |
GO:0062033 |
1.29% |
positive regulation of mitotic sister chromatid segregation |
GO:0031505 |
1.28% |
fungal-type cell wall organization |
GO:0051924 |
1.28% |
regulation of calcium ion transport |
GO:0090598 |
1.28% |
male anatomical structure morphogenesis |
GO:0051084 |
1.28% |
'de novo' posttranslational protein folding |
GO:2001252 |
1.28% |
positive regulation of chromosome organization |
GO:0000725 |
1.28% |
recombinational repair |
GO:0048771 |
1.28% |
tissue remodeling |
GO:0032008 |
1.28% |
positive regulation of TOR signaling |
GO:0070059 |
1.28% |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO:0043547 |
1.28% |
positive regulation of GTPase activity |
GO:0046456 |
1.28% |
icosanoid biosynthetic process |
GO:0019226 |
1.28% |
transmission of nerve impulse |
GO:1903532 |
1.28% |
positive regulation of secretion by cell |
GO:0048663 |
1.28% |
neuron fate commitment |
GO:0002429 |
1.27% |
immune response-activating cell surface receptor signaling pathway |
GO:0010575 |
1.27% |
positive regulation of vascular endothelial growth factor production |
GO:0014075 |
1.27% |
response to amine |
GO:0045429 |
1.27% |
positive regulation of nitric oxide biosynthetic process |
GO:0060191 |
1.27% |
regulation of lipase activity |
GO:0033280 |
1.27% |
response to vitamin D |
GO:0010259 |
1.27% |
multicellular organism aging |
GO:0060429 |
1.27% |
epithelium development |
GO:1901623 |
1.27% |
regulation of lymphocyte chemotaxis |
GO:1903307 |
1.27% |
positive regulation of regulated secretory pathway |
GO:0031152 |
1.27% |
aggregation involved in sorocarp development |
GO:0072594 |
1.27% |
establishment of protein localization to organelle |
GO:0061061 |
1.27% |
muscle structure development |
GO:0031396 |
1.27% |
regulation of protein ubiquitination |
GO:0021675 |
1.27% |
nerve development |
GO:0035148 |
1.27% |
tube formation |
GO:1904036 |
1.27% |
negative regulation of epithelial cell apoptotic process |
GO:1902895 |
1.27% |
positive regulation of pri-miRNA transcription by RNA polymerase II |
GO:0033005 |
1.27% |
positive regulation of mast cell activation |
GO:0016114 |
1.27% |
terpenoid biosynthetic process |
GO:0001935 |
1.26% |
endothelial cell proliferation |
GO:0006968 |
1.26% |
cellular defense response |
GO:0023014 |
1.26% |
signal transduction by protein phosphorylation |
GO:0042659 |
1.26% |
regulation of cell fate specification |
GO:0046887 |
1.26% |
positive regulation of hormone secretion |
GO:0000075 |
1.26% |
cell cycle checkpoint |
GO:0046632 |
1.26% |
alpha-beta T cell differentiation |
GO:0060999 |
1.26% |
positive regulation of dendritic spine development |
GO:0000077 |
1.26% |
DNA damage checkpoint |
GO:0033673 |
1.26% |
negative regulation of kinase activity |
GO:0071692 |
1.26% |
protein localization to extracellular region |
GO:0098586 |
1.26% |
cellular response to virus |
GO:0071555 |
1.26% |
cell wall organization |
GO:0071554 |
1.26% |
cell wall organization or biogenesis |
GO:0010667 |
1.25% |
negative regulation of cardiac muscle cell apoptotic process |
GO:0014032 |
1.25% |
neural crest cell development |
GO:0006836 |
1.25% |
neurotransmitter transport |
GO:0045621 |
1.25% |
positive regulation of lymphocyte differentiation |
GO:0019430 |
1.25% |
removal of superoxide radicals |
GO:0032928 |
1.25% |
regulation of superoxide anion generation |
GO:1904029 |
1.25% |
regulation of cyclin-dependent protein kinase activity |
GO:0007188 |
1.25% |
adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
GO:0009637 |
1.25% |
response to blue light |
GO:0043010 |
1.25% |
camera-type eye development |
GO:0032720 |
1.25% |
negative regulation of tumor necrosis factor production |
GO:0001835 |
1.25% |
blastocyst hatching |
GO:0006040 |
1.25% |
amino sugar metabolic process |
GO:0009190 |
1.25% |
cyclic nucleotide biosynthetic process |
GO:0051155 |
1.25% |
positive regulation of striated muscle cell differentiation |
GO:0034114 |
1.25% |
regulation of heterotypic cell-cell adhesion |
GO:0010332 |
1.25% |
response to gamma radiation |
GO:0061448 |
1.25% |
connective tissue development |
GO:1901568 |
1.25% |
fatty acid derivative metabolic process |
GO:0071826 |
1.25% |
ribonucleoprotein complex subunit organization |
GO:0050764 |
1.25% |
regulation of phagocytosis |
GO:0045671 |
1.24% |
negative regulation of osteoclast differentiation |
GO:1904707 |
1.24% |
positive regulation of vascular smooth muscle cell proliferation |
GO:0018904 |
1.24% |
ether metabolic process |
GO:0015914 |
1.24% |
phospholipid transport |
GO:0010288 |
1.24% |
response to lead ion |
GO:0051493 |
1.24% |
regulation of cytoskeleton organization |
GO:0006547 |
1.24% |
histidine metabolic process |
GO:0034587 |
1.24% |
piRNA metabolic process |
GO:1903556 |
1.24% |
negative regulation of tumor necrosis factor superfamily cytokine production |
GO:0099402 |
1.24% |
plant organ development |
GO:0055094 |
1.24% |
response to lipoprotein particle |
GO:0035112 |
1.24% |
genitalia morphogenesis |
GO:0000724 |
1.24% |
double-strand break repair via homologous recombination |
GO:1903793 |
1.23% |
positive regulation of anion transport |
GO:0016125 |
1.23% |
sterol metabolic process |
GO:2000401 |
1.23% |
regulation of lymphocyte migration |
GO:0031288 |
1.23% |
sorocarp morphogenesis |
GO:0008203 |
1.23% |
cholesterol metabolic process |
GO:0060147 |
1.23% |
regulation of posttranscriptional gene silencing |
GO:0033209 |
1.23% |
tumor necrosis factor-mediated signaling pathway |
GO:0019985 |
1.23% |
translesion synthesis |
GO:0033688 |
1.23% |
regulation of osteoblast proliferation |
GO:1900140 |
1.23% |
regulation of seedling development |
GO:0055076 |
1.23% |
transition metal ion homeostasis |
GO:0051769 |
1.23% |
regulation of nitric-oxide synthase biosynthetic process |
GO:0050804 |
1.22% |
modulation of chemical synaptic transmission |
GO:0035592 |
1.22% |
establishment of protein localization to extracellular region |
GO:0048592 |
1.22% |
eye morphogenesis |
GO:0000377 |
1.22% |
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
GO:0048026 |
1.22% |
positive regulation of mRNA splicing, via spliceosome |
GO:0060612 |
1.22% |
adipose tissue development |
GO:0006942 |
1.22% |
regulation of striated muscle contraction |
GO:0060964 |
1.22% |
regulation of gene silencing by miRNA |
GO:0010633 |
1.22% |
negative regulation of epithelial cell migration |
GO:0014888 |
1.22% |
striated muscle adaptation |
GO:0044282 |
1.22% |
small molecule catabolic process |
GO:0033365 |
1.22% |
protein localization to organelle |
GO:0051339 |
1.22% |
regulation of lyase activity |
GO:0030501 |
1.22% |
positive regulation of bone mineralization |
GO:0009948 |
1.22% |
anterior/posterior axis specification |
GO:0019369 |
1.22% |
arachidonic acid metabolic process |
GO:2000059 |
1.22% |
negative regulation of ubiquitin-dependent protein catabolic process |
GO:0034762 |
1.22% |
regulation of transmembrane transport |
GO:0031145 |
1.21% |
anaphase-promoting complex-dependent catabolic process |
GO:0044344 |
1.21% |
cellular response to fibroblast growth factor stimulus |
GO:0052652 |
1.21% |
cyclic purine nucleotide metabolic process |
GO:1900101 |
1.21% |
regulation of endoplasmic reticulum unfolded protein response |
GO:0043433 |
1.21% |
negative regulation of DNA-binding transcription factor activity |
GO:1901617 |
1.21% |
organic hydroxy compound biosynthetic process |
GO:0051495 |
1.21% |
positive regulation of cytoskeleton organization |
GO:0070168 |
1.21% |
negative regulation of biomineral tissue development |
GO:1900151 |
1.21% |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO:0042743 |
1.21% |
hydrogen peroxide metabolic process |
GO:0035115 |
1.20% |
embryonic forelimb morphogenesis |
GO:0015908 |
1.20% |
fatty acid transport |
GO:0000018 |
1.20% |
regulation of DNA recombination |
GO:2000736 |
1.20% |
regulation of stem cell differentiation |
GO:0014059 |
1.20% |
regulation of dopamine secretion |
GO:0034643 |
1.20% |
establishment of mitochondrion localization, microtubule-mediated |
GO:0006826 |
1.20% |
iron ion transport |
GO:0015849 |
1.20% |
organic acid transport |
GO:0010907 |
1.20% |
positive regulation of glucose metabolic process |
GO:0009306 |
1.20% |
protein secretion |
GO:0044770 |
1.20% |
cell cycle phase transition |
GO:0070873 |
1.20% |
regulation of glycogen metabolic process |
GO:0034243 |
1.20% |
regulation of transcription elongation from RNA polymerase II promoter |
GO:0071867 |
1.20% |
response to monoamine |
GO:0002090 |
1.20% |
regulation of receptor internalization |
GO:0060998 |
1.20% |
regulation of dendritic spine development |
GO:0071468 |
1.19% |
cellular response to acidic pH |
GO:0014014 |
1.19% |
negative regulation of gliogenesis |
GO:0120178 |
1.19% |
steroid hormone biosynthetic process |
GO:0007585 |
1.19% |
respiratory gaseous exchange by respiratory system |
GO:2000108 |
1.19% |
positive regulation of leukocyte apoptotic process |
GO:0048514 |
1.19% |
blood vessel morphogenesis |
GO:0010226 |
1.19% |
response to lithium ion |
GO:0051251 |
1.19% |
positive regulation of lymphocyte activation |
GO:0009260 |
1.19% |
ribonucleotide biosynthetic process |
GO:0055074 |
1.19% |
calcium ion homeostasis |
GO:0110150 |
1.19% |
negative regulation of biomineralization |
GO:0034105 |
1.19% |
positive regulation of tissue remodeling |
GO:0051651 |
1.19% |
maintenance of location in cell |
GO:0007127 |
1.19% |
meiosis I |
GO:0060966 |
1.19% |
regulation of gene silencing by RNA |
GO:0033045 |
1.19% |
regulation of sister chromatid segregation |
GO:0010389 |
1.19% |
regulation of G2/M transition of mitotic cell cycle |
GO:0000731 |
1.18% |
DNA synthesis involved in DNA repair |
GO:0051341 |
1.18% |
regulation of oxidoreductase activity |
GO:2000403 |
1.18% |
positive regulation of lymphocyte migration |
GO:0031398 |
1.18% |
positive regulation of protein ubiquitination |
GO:0070920 |
1.18% |
regulation of production of small RNA involved in gene silencing by RNA |
GO:0000165 |
1.18% |
MAPK cascade |
GO:0061515 |
1.18% |
myeloid cell development |
GO:0070206 |
1.18% |
protein trimerization |
GO:0010812 |
1.18% |
negative regulation of cell-substrate adhesion |
GO:0021766 |
1.18% |
hippocampus development |
GO:0070304 |
1.18% |
positive regulation of stress-activated protein kinase signaling cascade |
GO:0030947 |
1.18% |
regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0009909 |
1.18% |
regulation of flower development |
GO:0071684 |
1.18% |
organism emergence from protective structure |
GO:1903363 |
1.18% |
negative regulation of cellular protein catabolic process |
GO:0033619 |
1.17% |
membrane protein proteolysis |
GO:0006641 |
1.17% |
triglyceride metabolic process |
GO:0032892 |
1.17% |
positive regulation of organic acid transport |
GO:0050927 |
1.17% |
positive regulation of positive chemotaxis |
GO:0010965 |
1.17% |
regulation of mitotic sister chromatid separation |
GO:0043300 |
1.17% |
regulation of leukocyte degranulation |
GO:0045229 |
1.17% |
external encapsulating structure organization |
GO:1902235 |
1.17% |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO:0032330 |
1.17% |
regulation of chondrocyte differentiation |
GO:0048024 |
1.17% |
regulation of mRNA splicing, via spliceosome |
GO:1903432 |
1.17% |
regulation of TORC1 signaling |
GO:0006958 |
1.17% |
complement activation, classical pathway |
GO:0046628 |
1.17% |
positive regulation of insulin receptor signaling pathway |
GO:0071480 |
1.17% |
cellular response to gamma radiation |
GO:0006636 |
1.17% |
unsaturated fatty acid biosynthetic process |
GO:2000060 |
1.17% |
positive regulation of ubiquitin-dependent protein catabolic process |
GO:0071470 |
1.17% |
cellular response to osmotic stress |
GO:0002768 |
1.17% |
immune response-regulating cell surface receptor signaling pathway |
GO:0006302 |
1.17% |
double-strand break repair |
GO:0032874 |
1.16% |
positive regulation of stress-activated MAPK cascade |
GO:1901522 |
1.16% |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
GO:0061726 |
1.16% |
mitochondrion disassembly |
GO:0042634 |
1.16% |
regulation of hair cycle |
GO:0032944 |
1.16% |
regulation of mononuclear cell proliferation |
GO:1903900 |
1.16% |
regulation of viral life cycle |
GO:0014912 |
1.16% |
negative regulation of smooth muscle cell migration |
GO:0006941 |
1.16% |
striated muscle contraction |
GO:0090288 |
1.16% |
negative regulation of cellular response to growth factor stimulus |
GO:0003044 |
1.16% |
regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0009855 |
1.16% |
determination of bilateral symmetry |
GO:1902749 |
1.16% |
regulation of cell cycle G2/M phase transition |
GO:0051973 |
1.16% |
positive regulation of telomerase activity |
GO:0019935 |
1.16% |
cyclic-nucleotide-mediated signaling |
GO:0008360 |
1.16% |
regulation of cell shape |
GO:0048569 |
1.15% |
post-embryonic animal organ development |
GO:0051983 |
1.15% |
regulation of chromosome segregation |
GO:0048168 |
1.15% |
regulation of neuronal synaptic plasticity |
GO:0051146 |
1.15% |
striated muscle cell differentiation |
GO:0045773 |
1.15% |
positive regulation of axon extension |
GO:0045931 |
1.15% |
positive regulation of mitotic cell cycle |
GO:0046942 |
1.15% |
carboxylic acid transport |
GO:0060485 |
1.15% |
mesenchyme development |
GO:0060348 |
1.15% |
bone development |
GO:0006026 |
1.15% |
aminoglycan catabolic process |
GO:0090407 |
1.15% |
organophosphate biosynthetic process |
GO:0042753 |
1.15% |
positive regulation of circadian rhythm |
GO:0050708 |
1.15% |
regulation of protein secretion |
GO:1903827 |
1.15% |
regulation of cellular protein localization |
GO:0002209 |
1.15% |
behavioral defense response |
GO:0010029 |
1.15% |
regulation of seed germination |
GO:0043330 |
1.14% |
response to exogenous dsRNA |
GO:0032392 |
1.14% |
DNA geometric change |
GO:0006521 |
1.14% |
regulation of cellular amino acid metabolic process |
GO:2001032 |
1.14% |
regulation of double-strand break repair via nonhomologous end joining |
GO:0045806 |
1.14% |
negative regulation of endocytosis |
GO:0071621 |
1.14% |
granulocyte chemotaxis |
GO:0002040 |
1.14% |
sprouting angiogenesis |
GO:0016241 |
1.14% |
regulation of macroautophagy |
GO:0002701 |
1.14% |
negative regulation of production of molecular mediator of immune response |
GO:0006359 |
1.14% |
regulation of transcription by RNA polymerase III |
GO:1904951 |
1.13% |
positive regulation of establishment of protein localization |
GO:0042762 |
1.13% |
regulation of sulfur metabolic process |
GO:1903522 |
1.13% |
regulation of blood circulation |
GO:0000079 |
1.13% |
regulation of cyclin-dependent protein serine/threonine kinase activity |
GO:0032352 |
1.13% |
positive regulation of hormone metabolic process |
GO:0008016 |
1.13% |
regulation of heart contraction |
GO:0006364 |
1.13% |
rRNA processing |
GO:0061005 |
1.13% |
cell differentiation involved in kidney development |
GO:0006298 |
1.13% |
mismatch repair |
GO:0048286 |
1.13% |
lung alveolus development |
GO:0007368 |
1.13% |
determination of left/right symmetry |
GO:0014048 |
1.13% |
regulation of glutamate secretion |
GO:0001782 |
1.13% |
B cell homeostasis |
GO:0021953 |
1.13% |
central nervous system neuron differentiation |
GO:0000105 |
1.13% |
histidine biosynthetic process |
GO:0048806 |
1.13% |
genitalia development |
GO:0007517 |
1.12% |
muscle organ development |
GO:0006887 |
1.12% |
exocytosis |
GO:0007339 |
1.12% |
binding of sperm to zona pellucida |
GO:0001569 |
1.12% |
branching involved in blood vessel morphogenesis |
GO:0044403 |
1.12% |
symbiotic process |
GO:1901798 |
1.12% |
positive regulation of signal transduction by p53 class mediator |
GO:0034470 |
1.12% |
ncRNA processing |
GO:0043632 |
1.12% |
modification-dependent macromolecule catabolic process |
GO:0090150 |
1.12% |
establishment of protein localization to membrane |
GO:0043270 |
1.12% |
positive regulation of ion transport |
GO:0010656 |
1.12% |
negative regulation of muscle cell apoptotic process |
GO:0051353 |
1.12% |
positive regulation of oxidoreductase activity |
GO:0016311 |
1.12% |
dephosphorylation |
GO:0033143 |
1.12% |
regulation of intracellular steroid hormone receptor signaling pathway |
GO:0006910 |
1.12% |
phagocytosis, recognition |
GO:0019941 |
1.12% |
modification-dependent protein catabolic process |
GO:0050868 |
1.12% |
negative regulation of T cell activation |
GO:0045124 |
1.12% |
regulation of bone resorption |
GO:0031648 |
1.12% |
protein destabilization |
GO:0007520 |
1.11% |
myoblast fusion |
GO:0048713 |
1.11% |
regulation of oligodendrocyte differentiation |
GO:0000578 |
1.11% |
embryonic axis specification |
GO:0006366 |
1.11% |
transcription by RNA polymerase II |
GO:1901739 |
1.11% |
regulation of myoblast fusion |
GO:0045739 |
1.11% |
positive regulation of DNA repair |
GO:0042168 |
1.11% |
heme metabolic process |
GO:0031069 |
1.11% |
hair follicle morphogenesis |
GO:0008088 |
1.11% |
axo-dendritic transport |
GO:1902019 |
1.11% |
regulation of cilium-dependent cell motility |
GO:0046631 |
1.11% |
alpha-beta T cell activation |
GO:0002720 |
1.11% |
positive regulation of cytokine production involved in immune response |
GO:0015844 |
1.11% |
monoamine transport |
GO:0033077 |
1.11% |
T cell differentiation in thymus |
GO:0070229 |
1.11% |
negative regulation of lymphocyte apoptotic process |
GO:0044242 |
1.11% |
cellular lipid catabolic process |
GO:1903901 |
1.11% |
negative regulation of viral life cycle |
GO:0007588 |
1.11% |
excretion |
GO:0006778 |
1.11% |
porphyrin-containing compound metabolic process |
GO:0070507 |
1.10% |
regulation of microtubule cytoskeleton organization |
GO:0071398 |
1.10% |
cellular response to fatty acid |
GO:0034293 |
1.10% |
sexual sporulation |
GO:0031056 |
1.10% |
regulation of histone modification |
GO:0002764 |
1.10% |
immune response-regulating signaling pathway |
GO:0090207 |
1.10% |
regulation of triglyceride metabolic process |
GO:0097755 |
1.10% |
positive regulation of blood vessel diameter |
GO:0046888 |
1.10% |
negative regulation of hormone secretion |
GO:0022404 |
1.10% |
molting cycle process |
GO:0071852 |
1.10% |
fungal-type cell wall organization or biogenesis |
GO:0010884 |
1.10% |
positive regulation of lipid storage |
GO:0060456 |
1.10% |
positive regulation of digestive system process |
GO:1901983 |
1.09% |
regulation of protein acetylation |
GO:0000422 |
1.09% |
autophagy of mitochondrion |
GO:1903524 |
1.09% |
positive regulation of blood circulation |
GO:0110053 |
1.09% |
regulation of actin filament organization |
GO:0016055 |
1.09% |
Wnt signaling pathway |
GO:0010447 |
1.09% |
response to acidic pH |
GO:0008277 |
1.09% |
regulation of G protein-coupled receptor signaling pathway |
GO:0043388 |
1.09% |
positive regulation of DNA binding |
GO:0014896 |
1.09% |
muscle hypertrophy |
GO:0001657 |
1.09% |
ureteric bud development |
GO:1902903 |
1.09% |
regulation of supramolecular fiber organization |
GO:0007007 |
1.09% |
inner mitochondrial membrane organization |
GO:0014743 |
1.09% |
regulation of muscle hypertrophy |
GO:0035036 |
1.09% |
sperm-egg recognition |
GO:0043484 |
1.09% |
regulation of RNA splicing |
GO:0001837 |
1.09% |
epithelial to mesenchymal transition |
GO:0015979 |
1.09% |
photosynthesis |
GO:0007159 |
1.08% |
leukocyte cell-cell adhesion |
GO:1903829 |
1.08% |
positive regulation of cellular protein localization |
GO:0006664 |
1.08% |
glycolipid metabolic process |
GO:0010596 |
1.08% |
negative regulation of endothelial cell migration |
GO:0032692 |
1.08% |
negative regulation of interleukin-1 production |
GO:0000226 |
1.08% |
microtubule cytoskeleton organization |
GO:0032890 |
1.08% |
regulation of organic acid transport |
GO:0046850 |
1.08% |
regulation of bone remodeling |
GO:0032691 |
1.08% |
negative regulation of interleukin-1 beta production |
GO:0022409 |
1.08% |
positive regulation of cell-cell adhesion |
GO:0006446 |
1.08% |
regulation of translational initiation |
GO:0072175 |
1.08% |
epithelial tube formation |
GO:0046685 |
1.07% |
response to arsenic-containing substance |
GO:0030031 |
1.07% |
cell projection assembly |
GO:0006119 |
1.07% |
oxidative phosphorylation |
GO:1902275 |
1.07% |
regulation of chromatin organization |
GO:0009624 |
1.07% |
response to nematode |
GO:0042254 |
1.07% |
ribosome biogenesis |
GO:0046337 |
1.07% |
phosphatidylethanolamine metabolic process |
GO:2000756 |
1.07% |
regulation of peptidyl-lysine acetylation |
GO:0044319 |
1.07% |
wound healing, spreading of cells |
GO:0001953 |
1.07% |
negative regulation of cell-matrix adhesion |
GO:0009595 |
1.07% |
detection of biotic stimulus |
GO:0035264 |
1.07% |
multicellular organism growth |
GO:0070849 |
1.07% |
response to epidermal growth factor |
GO:0046825 |
1.07% |
regulation of protein export from nucleus |
GO:0000398 |
1.06% |
mRNA splicing, via spliceosome |
GO:0035813 |
1.06% |
regulation of renal sodium excretion |
GO:0031098 |
1.06% |
stress-activated protein kinase signaling cascade |
GO:0045933 |
1.06% |
positive regulation of muscle contraction |
GO:0032508 |
1.06% |
DNA duplex unwinding |
GO:0098581 |
1.06% |
detection of external biotic stimulus |
GO:0016054 |
1.06% |
organic acid catabolic process |
GO:0006690 |
1.06% |
icosanoid metabolic process |
GO:0048010 |
1.06% |
vascular endothelial growth factor receptor signaling pathway |
GO:0045823 |
1.06% |
positive regulation of heart contraction |
GO:0045069 |
1.06% |
regulation of viral genome replication |
GO:0043407 |
1.06% |
negative regulation of MAP kinase activity |
GO:1903747 |
1.06% |
regulation of establishment of protein localization to mitochondrion |
GO:0009630 |
1.06% |
gravitropism |
GO:1905475 |
1.06% |
regulation of protein localization to membrane |
GO:0030593 |
1.06% |
neutrophil chemotaxis |
GO:0010518 |
1.06% |
positive regulation of phospholipase activity |
GO:0042311 |
1.05% |
vasodilation |
GO:0070252 |
1.05% |
actin-mediated cell contraction |
GO:0099111 |
1.05% |
microtubule-based transport |
GO:0006656 |
1.05% |
phosphatidylcholine biosynthetic process |
GO:0001556 |
1.05% |
oocyte maturation |
GO:0007492 |
1.05% |
endoderm development |
GO:0098926 |
1.05% |
postsynaptic signal transduction |
GO:0000280 |
1.05% |
nuclear division |
GO:0007163 |
1.05% |
establishment or maintenance of cell polarity |
GO:2001057 |
1.05% |
reactive nitrogen species metabolic process |
GO:0009112 |
1.05% |
nucleobase metabolic process |
GO:0010800 |
1.05% |
positive regulation of peptidyl-threonine phosphorylation |
GO:0098657 |
1.05% |
import into cell |
GO:0007297 |
1.04% |
ovarian follicle cell migration |
GO:0060281 |
1.04% |
regulation of oocyte development |
GO:0060968 |
1.04% |
regulation of gene silencing |
GO:0045921 |
1.04% |
positive regulation of exocytosis |
GO:0045055 |
1.04% |
regulated exocytosis |
GO:0045980 |
1.04% |
negative regulation of nucleotide metabolic process |
GO:1903509 |
1.04% |
liposaccharide metabolic process |
GO:0060688 |
1.04% |
regulation of morphogenesis of a branching structure |
GO:0048013 |
1.04% |
ephrin receptor signaling pathway |
GO:1900006 |
1.04% |
positive regulation of dendrite development |
GO:0090596 |
1.04% |
sensory organ morphogenesis |
GO:1902884 |
1.04% |
positive regulation of response to oxidative stress |
GO:0032663 |
1.04% |
regulation of interleukin-2 production |
GO:0030316 |
1.04% |
osteoclast differentiation |
GO:0010828 |
1.04% |
positive regulation of glucose transmembrane transport |
GO:0090049 |
1.04% |
regulation of cell migration involved in sprouting angiogenesis |
GO:0042773 |
1.03% |
ATP synthesis coupled electron transport |
GO:0017001 |
1.03% |
antibiotic catabolic process |
GO:0051457 |
1.03% |
maintenance of protein location in nucleus |
GO:0046395 |
1.03% |
carboxylic acid catabolic process |
GO:0009152 |
1.03% |
purine ribonucleotide biosynthetic process |
GO:0007088 |
1.03% |
regulation of mitotic nuclear division |
GO:0046688 |
1.03% |
response to copper ion |
GO:0050670 |
1.03% |
regulation of lymphocyte proliferation |
GO:0002244 |
1.03% |
hematopoietic progenitor cell differentiation |
GO:1903037 |
1.03% |
regulation of leukocyte cell-cell adhesion |
GO:0006692 |
1.03% |
prostanoid metabolic process |
GO:0002757 |
1.03% |
immune response-activating signal transduction |
GO:0001659 |
1.03% |
temperature homeostasis |
GO:0006305 |
1.03% |
DNA alkylation |
GO:0010574 |
1.03% |
regulation of vascular endothelial growth factor production |
GO:0098930 |
1.03% |
axonal transport |
GO:0090502 |
1.03% |
RNA phosphodiester bond hydrolysis, endonucleolytic |
GO:0034695 |
1.02% |
response to prostaglandin E |
GO:0006325 |
1.02% |
chromatin organization |
GO:0048701 |
1.02% |
embryonic cranial skeleton morphogenesis |
GO:1903051 |
1.02% |
negative regulation of proteolysis involved in cellular protein catabolic process |
GO:0007265 |
1.02% |
Ras protein signal transduction |
GO:0030203 |
1.02% |
glycosaminoglycan metabolic process |
GO:0002181 |
1.02% |
cytoplasmic translation |
GO:0048871 |
1.02% |
multicellular organismal homeostasis |
GO:1900426 |
1.02% |
positive regulation of defense response to bacterium |
GO:0045727 |
1.02% |
positive regulation of translation |
GO:0010718 |
1.02% |
positive regulation of epithelial to mesenchymal transition |
GO:0050851 |
1.02% |
antigen receptor-mediated signaling pathway |
GO:0072507 |
1.02% |
divalent inorganic cation homeostasis |
GO:0006338 |
1.02% |
chromatin remodeling |
GO:0050770 |
1.02% |
regulation of axonogenesis |
GO:0010517 |
1.02% |
regulation of phospholipase activity |
GO:0006875 |
1.02% |
cellular metal ion homeostasis |
GO:0045672 |
1.01% |
positive regulation of osteoclast differentiation |
GO:0033047 |
1.01% |
regulation of mitotic sister chromatid segregation |
GO:0008654 |
1.01% |
phospholipid biosynthetic process |
GO:0002706 |
1.01% |
regulation of lymphocyte mediated immunity |
GO:0032354 |
1.01% |
response to follicle-stimulating hormone |
GO:0000959 |
1.01% |
mitochondrial RNA metabolic process |
GO:1904666 |
1.01% |
regulation of ubiquitin protein ligase activity |
GO:2000772 |
1.01% |
regulation of cellular senescence |
GO:0001990 |
1.01% |
regulation of systemic arterial blood pressure by hormone |
GO:1901970 |
1.01% |
positive regulation of mitotic sister chromatid separation |
GO:0010863 |
1.01% |
positive regulation of phospholipase C activity |
GO:1903038 |
1.01% |
negative regulation of leukocyte cell-cell adhesion |
GO:0050926 |
1.01% |
regulation of positive chemotaxis |
GO:0019318 |
1.01% |
hexose metabolic process |
GO:0009799 |
1.01% |
specification of symmetry |
GO:0031047 |
1.01% |
gene silencing by RNA |
GO:0060143 |
1.01% |
positive regulation of syncytium formation by plasma membrane fusion |
GO:0043302 |
1.01% |
positive regulation of leukocyte degranulation |
GO:2000142 |
1.01% |
regulation of DNA-templated transcription, initiation |
GO:0006122 |
1.01% |
mitochondrial electron transport, ubiquinol to cytochrome c |
GO:0042447 |
1.00% |
hormone catabolic process |
GO:0046390 |
1.00% |
ribose phosphate biosynthetic process |
GO:0032259 |
1.00% |
methylation |
GO:0001975 |
1.00% |
response to amphetamine |
GO:0046189 |
1.00% |
phenol-containing compound biosynthetic process |
GO:0022613 |
1.00% |
ribonucleoprotein complex biogenesis |
GO:0006027 |
1.00% |
glycosaminoglycan catabolic process |
GO:0000712 |
1.00% |
resolution of meiotic recombination intermediates |
GO:1902993 |
1.00% |
positive regulation of amyloid precursor protein catabolic process |
GO:0002822 |
1.00% |
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |